|
|
![]() | ![]() | ![]() | ![]() |
On Assignment 10-K 2010 Documents found in this filing:UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM 10-K
SECURITIES
EXCHANGE ACT OF 1934
For
the fiscal year ended December 31, 2009
SECURITIES
EXCHANGE ACT OF 1934
Commission
File Number 0-20540
ON
ASSIGNMENT, INC.
(Exact
name of registrant as specified in its charter)
26651
West Agoura Road
Calabasas, California 91302
(Address
of Principal Executive Offices)
Registrant’s
telephone number, including area code (818)
878-7900
Securities
registered pursuant to Section 12(b) of the Act:
Securities
registered pursuant to Section 12(g) of the Act:
None
(Title of
Class)
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in
Rule 405 of the Securities Act. Yes o No x
Indicate
by check mark if the registrant is not required to file reports pursuant to
Section 13 or Section 15(d) of the Act. Yes o No x
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements of the past 90 days. Yes x No o
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding
12 months (or for such shorter period that the registrant was required to submit
and post such files). Yes No
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of
Regulation S-K is not contained herein, and will not be contained, to the best
of registrant’s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. o
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer or a smaller reporting company. See
the definitions of “large accelerated filer,” “accelerated filer” and
“smaller reporting company” in Rule 12b-2 of the Exchange Act.
Indicate
by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes o No x
As of
June 30, 2009, the aggregate market value of our common stock held by
non-affiliates of the registrant was approximately $93,459,068.
As of
March 10, 2010, the registrant had outstanding 36,371,091 shares of Common
Stock, $0.01 par value.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions
of the registrant’s proxy statement for the 2010 Annual Meeting of Stockholders,
to be filed within 120 days of the close of the registrant’s fiscal year 2009,
are incorporated by reference into Part III of this Annual Report on
Form 10-K.
ON
ASSIGNMENT, INC.
ANNUAL
REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009
TABLE
OF CONTENTS
2
SPECIAL
NOTE ON FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K
contains forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. Such statements are based upon current expectations, as
well as management’s beliefs and assumptions, and involve a high degree of risk
and uncertainty. Any statements contained herein that are not statements of
historical fact may be deemed to be forward-looking statements. Statements that
include the words “believes,” “anticipates,” “plans,” “expects,” “intends,” and
similar expressions that convey uncertainty of future events or outcomes are
forward-looking statements. Forward-looking statements include statements
regarding our anticipated financial and operating performance for future
periods. Our actual results could differ materially from those discussed or
suggested in the forward-looking statements herein. Factors that could cause or
contribute to these differences or prove our forward-looking statements, by
hindsight, to be overly optimistic or unachievable include, but are not limited
to actual demand for our services, our ability to attract, train, and retain
qualified staffing consultants (which includes our sales and recruiting staff),
our ability to remain competitive in obtaining and retaining temporary staffing
clients, the availability of qualified temporary nurses and other qualified
contract professionals, our ability to manage our growth efficiently and
effectively, continued performance of our information systems and the factors
described in Item 1A of this Annual Report on Form 10-K under the Section titled
”Risk Factors.” Other factors also may contribute to the differences between our
forward-looking statements and our actual results. In addition, as a result of
these and other factors, our past financial performance should not be relied on
as an indication of future performance. All forward-looking statements in this
document are based on information available to us as of the date we file this
Annual Report on Form 10-K, and we assume no obligation to update any
forward-looking statement or the reasons why our actual results may
differ. 3
Item
1. Business
Overview
and History
On
Assignment, Inc. is a diversified professional staffing firm providing
flexible and permanent staffing solutions in specialty skills including
Laboratory/Scientific, Healthcare/Nursing, Physician, Medical Financial,
Information Technology and Engineering. We provide clients in these markets with
short-term or long-term assignments of contract
professionals, contract-to-permanent placement and direct placement of
these professionals. As of December 31, 2009, our business consists of four
operating segments: Life Sciences, Healthcare, Physician and IT and
Engineering.
Our Life
Sciences segment includes our domestic and international life science staffing
businesses. Life Sciences segment revenues for 2009 were $93.7 million and
represented 22.5 percent of our total revenues. We provide locally-based
contract life science professionals to clients in the biotechnology,
pharmaceutical, food and beverage, medical device, personal care, chemical,
automotive, educational and environmental industries. Our contract professionals
include chemists, clinical research associates, clinical lab assistants,
engineers, biologists, biochemists, microbiologists, molecular biologists, food
scientists, regulatory affairs specialists, lab assistants and other skilled
scientific professionals.
Our
Healthcare segment includes our Nurse Travel and Allied Healthcare lines of
business. Healthcare segment revenues for 2009 were $97.1 million and
represented 23.3 percent of our total revenues. We offer our healthcare clients
locally-based and traveling contract professionals, from more than ten
healthcare and medical financial and allied occupations. Our contract
professionals include nurses, specialty nurses, health information management
professionals, dialysis technicians, surgical technicians, imaging technicians,
x-ray technicians, medical technologists, phlebotomists, coders, billers, claims
processors and collections staff.
Our
Physician segment consists of VISTA Staffing Solutions, Inc. (VISTA), which we
acquired on January 3, 2007. The Physician segment revenues for 2009 were $87.7
million and represented 21.1 percent of our total revenues. VISTA, based in Salt
Lake City, Utah, is a leading provider of physician staffing, known as locum
tenens, and permanent physician search services. We provide short and long-term
locum tenens services and full-service physician search and consulting services,
primarily in the United States, with some locum tenens placements in Australia
and New Zealand. We work with physicians in a wide range of specialties, placing
them in hospitals, community-based practices and federal, state and local
facilities.
Our IT
and Engineering segment consists of Oxford Global Resources, Inc. (Oxford) which
we acquired on January 31, 2007. IT and Engineering segment revenues
for 2009 were $138.1 million and represented 33.1 percent of our total revenues.
Oxford, based in Beverly, Massachusetts, delivers high-end consultants with
expertise in specialized information technology, hardware and software
engineering and mechanical, electrical, validation and telecommunications
engineering fields. We combine international reach with local depth, serving
clients through a network of Oxford International recruiting centers in the
United States and Europe, and Oxford & Associates branch offices in major
metropolitan markets across the United States.
We were
incorporated on December 30, 1985, and thereafter commenced operation of
our Lab Support line of business (now included in our Life Sciences operating
segment), our first contract staffing line of business. Utilizing our experience
and unique approach in servicing our clients and contract professionals, we
expanded our operations into other industries requiring specialty staffing. In
1994, through our acquisition of 1st
Choice Personnel, Inc. and Sklar Resource Group, Inc., we established
our Healthcare Financial Staffing service line of business (now a part of our
Healthcare operating segment). Originally named Finance Support, this service
line of business changed its name in 1997 and shifted in its business
development focus to medical billing and collections for hospitals, health
management organizations and physician groups. In 1996, we acquired Enviro Staff, and began providing
contract professionals to the environmental services industry. In 1998, we
acquired LabStaffers, Inc. to enhance our Life Sciences business. In 1999,
we expanded our Life Sciences operations into Europe. Also in 1999, we formed
our Clinical Lab Staff service line of business, and in 2001, we formed our
Diagnostic Imaging Staff service line of business. Both of these service lines
of business provide scientific and medical professionals to hospitals,
physicians’ offices, clinics, reference laboratories and HMO’s and are currently
included as a part of our Healthcare segment. In 2002, we acquired Health
Personnel Options Corporation, and established our Nurse Travel line of
business, which provides registered nurses to hospitals and managed healthcare
organizations. In 2003, we expanded the service offerings for our Life Sciences
operating segment to include clinical research and engineering. Our clinical
research line of business provides life science professionals in medical and
clinical trial research, and our engineering line of business provides contract
professionals in manufacturing, packaging, research and development and quality
control positions. In 2004, we expanded our service offerings in our Healthcare
operating segment to include local nursing
and health information management, which provides health information
professionals to healthcare clients to process insurance claims and manage
patient data. On January 3, 2007, we acquired VISTA and established our
Physician operating segment. On January 31, 2007, we acquired Oxford and
established our IT and Engineering operating segment. On October 1, 2009, we
acquired Fox Hill & Associates, a physician permanent placement business
specializing in retained and contingent search, which is included in our
Physician operating segment. The company was founded in 1978 and is
located in Milwaukee, Wisconsin. 4
Financial
information regarding our operating segments and our domestic and international
revenues are included under “Financial Statements and Supplementary Data” in
Part II, Item 8 of this Annual Report.
Our
principal executive office is located at 26651 West Agoura Road, Calabasas,
California 91302, and our telephone number is (818) 878-7900. We have
approximately 73 branch offices in 23 states within the United States and in
five foreign countries.
Industry
and Market Dynamics
General
Though
the most recent U.S. employment figures indicate a significant contraction in
job growth rates, from late 2007 through the present, the U.S. Bureau of Labor
Statistics estimates that total employment will grow by 15.3 million jobs, or 10
percent, between 2008 and 2018. By comparison, there were 10.4 million new jobs
created in the prior ten-year period, between 1998 and 2008. The U.S. Bureau of
Labor Statistics estimates that employment growth will continue to be
concentrated in the service sector with healthcare and social assistance, and
professional and business services providing the strongest employment
growth.
The Staffing Industry Analysts:
Staffing Industry Report (dated January 2010), an independent staffing
industry publication, estimates that total staffing industry revenues were $93
billion in 2009 and will be $97 billion in 2010, down from $127 billion in 2008.
The biggest industry segment, contract labor, is forecasted to grow at an annual
rate of 7 percent in 2010 with revenues of $76 billion in 2010, while permanent
placement is expected to contract by 5 percent in 2010. Within the contract help
segment, professional staffing is expected to grow at an annual rate of 5
percent in 2010 to revenues of $43 billion. While the current economic climate
has affected the staffing industry, we believe healthcare, life sciences and IT
clients will increase their use of outsourced labor through professional
staffing firms. By using outsourced labor, these end users will benefit from
cost structure advantages, improved flexibility to fluctuating demand in
business and access to greater expertise. Typically, life sciences and
healthcare clients’ products directly influence an individual’s health, welfare
and well being, which will also impact our customers’ decision to use our
services.
Life
Sciences
The Staffing Industry Analysts: Staffing
Industry Report (dated January 2010), states that the life sciences
professional staffing market will remain flat in 2010 compared to 2009. Demand
for staffing in our Life Sciences segment is driven primarily by clients with
research and development projects across a wide array of
industries.
Our Life
Sciences segment includes our domestic and international life science staffing
businesses. We provide locally-based, contract life science professionals to
clients in the biotechnology, pharmaceutical, food and beverage, personal care,
chemical, medical device, automotive, municipal, education and environmental
industries. Our Life Sciences segment operates from local branch offices in the
United States, United Kingdom, Netherlands, Belgium and Canada.
The Staffing Industry Analysts:
Staffing Industry Report (dated January 2010), estimates that the
healthcare staffing market will contract by 1 percent in 2010. Within the
healthcare staffing industry, allied health and locum tenens remain the areas
that are most resilient to changing economic conditions with estimated 2010
revenue growth of 2 percent and 3 percent, respectively.
In prior
years, nursing employment levels were affected by cutbacks in the use of agency
workers by hospitals and medical groups and their reluctance to pay market
rates. Today, as a result of the economy, hospitals are seeing fewer admissions
and procedures and are attempting to minimize expenses, which in turn have
impacted the demand for our services. Looking forward, contract nursing
employment growth could potentially be driven by various factors including a
supply shortage of nurses, more favorable nurse-patient ratios and an aging
population.
5
The
combination of healthcare clients facing shortages of operations-critical staff
that limit their ability to generate revenues, increased demand for health
services and advances in life
science and medical technology is expected to create significant demand for
workers with specialized science and medical skills. Also influencing the demand
for these workers is the departure of mature professionals from the ranks of
full-time employment as they retire, reduce hours worked and pursue other career
opportunities. This is evidenced by the continued increase in the
average age of nurses in the workforce.
Our
Healthcare segment provides locally-based and traveling contract professionals
to healthcare clients, including hospitals, integrated delivery systems, imaging
centers, clinics, physician offices, reference laboratories, universities,
managed care organizations and third-party administrators.
Physician
The Staffing Industry Analysts: Staffing
Industry Report (dated January 2010), states that the physician staffing
market will increase 3 percent in 2010. This is one of the fastest growing
sectors of the staffing markets. An ongoing shortage of physicians is fueling
this growth.
Our
Physician staffing business places physicians in a wide range of specialties
throughout the United States, as well as Australia and New Zealand, under the
brand VISTA. The physician staffing market requires a high degree of specialized
knowledge about credentialing and qualifications, as well as unique insurance
requirements that make it more difficult to replicate than certain other types
of staffing markets. Our Physician segment operates out of one primary
recruitment center with several branch offices.
IT
and Engineering
The Staffing Industry Analysts:
Staffing Industry Report (dated January 2010), estimates that the IT
staffing market will increase 8 percent in 2010. Demand in our IT and
Engineering business segment is driven by a shortage of highly skilled
professionals with specific expertise.
Our IT
and Engineering segment places only very highly qualified professionals across a
wide range of disciplines. The segment operates out of several large sales and
recruitment centers including one in Cork, Ireland under the brand Oxford
International, and a number of domestic branch offices under the brand Oxford
& Associates. Placements are highly diversified in that we average less than
two contract placements per client. In late 2009, Oxford re-opened a permanent
placement recruitment business.
Sales
and Fulfillment
General
Our
strategy is to serve the needs of our targeted industries by effectively
understanding and matching client staffing needs with qualified contract
professionals. In contrast to the mass market approach generally used for
contract office/clerical and light industrial personnel, we believe effective
assignments of contract healthcare, life science, physician and IT and
engineering professionals require the people involved in making assignments to
have significant knowledge of the client’s industry and the ability to assess
the specific needs of the client as well as the contract professionals’
qualifications. We believe that face-to-face selling in many circumstances is
significantly more effective than the telephonic solicitation of clients, a
tactic favored by many of our competitors. We believe our strategy of using
industry professionals to develop professional relationships provides us with a
competitive advantage in our industry which is recognized by our
clients.
Our
corporate offices are organized to perform many functions that allow staffing
consultants and recruiters to focus more effectively on business development and
the assignment of contract professionals. These functions include the recruiting
and hiring of staffing consultants, recruiters and support staff, as well as
ongoing training, coaching and administrative support. Our corporate offices
also select, open and maintain branch offices.
We have
developed a tailored approach to the assignment-making process that utilizes
staffing consultants. Unlike traditional approaches that tend to be focused on
telephonic solicitation, our Life Sciences staffing consultants are experienced
professionals who work in our branch office network in the United States, United
Kingdom, Netherlands, Belgium and Canada to enable face-to-face meetings with
clients and contract professionals. At December 31, 2009, we had 40 Life
Sciences segment branch offices. Most of our staffing consultants are either
focused on sales and business development or on fulfillment. Sales and business
development staffing consultants meet with clients’ managers to understand
client needs, formulate position descriptions and assess workplace environments.
Fulfillment staffing consultants meet with candidates to assess their
qualifications and interests and place these contract professionals on quality
assignments with clients. 6
Contract
professionals assigned to clients are generally our employees, although clients
provide on-the-job supervisors for these professionals. Therefore, clients
control and direct the work of contract professionals and approve hours worked,
while we are responsible for many of the activities typically handled by the
client’s human resources department.
The
sales, account management, and recruiting functions of our Nurse Travel
business are aligned with traditional nurse travel companies with an added
emphasis on rapid response fulfillment. We employ regional sales directors
and account managers to identify and sell a variety of nurse staffing solutions
to health care clients nationally. Our recruiters seek the most
experienced, highly skilled nurses and place them on assignments as contract
professionals with healthcare providers for periods ranging from four to
twenty-six weeks and longer. We service a diverse collection of healthcare
clients, including acute care hospitals, rehabilitation facilities, long-term
care facilities and integrated delivery systems. We seek to address
occupations that represent “high demand and highly-skilled” staff such as
emergency room, pediatrics, intensive care and operating room nurses, which are
essential to maintaining the hospital’s ability to care for patients and
maintain business and revenues. The critical nature of these occupations to
drive revenue motivates clients to respond to our ability to rapidly fill open
positions with experienced nurses. The recruitment and placement of nurse travel
assignments are primarily managed at our locations in Cincinnati, Ohio, Tupelo,
Mississippi and San Diego, California.
The
nurses we assign to our clients are our employees, although clients provide
on-the-job supervisors for the nurses. Therefore, clients control and direct the
work of nurses and approve hours worked, while we are responsible for many of
the activities typically handled by the client’s human resources
department.
At
December 31, 2009, we had 24 Allied Healthcare branch offices in the United
States, of which 12 share office space with the Life Sciences segment. We have
developed a tailored approach to the assignment-making process that utilizes
staffing consultants. Staffing consultants are experienced professionals who
work in our branch offices and personally meet with clients and contract
professionals. Our staffing consultants are typically either focused primarily
on sales and business development or on fulfillment. Sales and business
development staffing consultants meet with clients to understand their staffing
needs, formulate position descriptions and assess workplace environments.
Fulfillment staffing consultants meet with candidates to assess their
qualifications and interests and place these contract professionals on quality
assignments with clients.
The
contract professionals assigned to our Allied Healthcare clients are usually our
employees, although clients provide on-the-job supervisors for these
professionals. Therefore, clients control and direct the work of contract
professionals and approve hours worked, while we are responsible for many of the
activities typically handled by the client’s human resources
department.
Physician
The sales
and fulfillment functions at our Physician segment are similar to those of our
competitors. Our client sales specialists are organized by geographic
territories so that a single individual can handle a client’s physician staffing
needs for all disciplines. Our recruiters and schedulers are organized by
physician specialty and identify physician candidates with the skills,
experience and availability to meet our clients’ needs. Our Physician business
is headquartered in Salt Lake City, Utah, where the majority of our recruiters
and all back-office functions are located. In addition, we have four branch
locations that also carry out recruiting functions. We supply doctors in a wide
range of specialties throughout the United States, Australia and New Zealand.
Assignments are typically booked up to three months in advance and last six
weeks.
The
physicians we place at clients are independent contractors. Clients assign
shifts and approve hours worked, while we are responsible for issuing payments
to the physicians for services rendered to our clients.
IT
and Engineering
Our IT
and Engineering segment is headquartered outside of Boston, Massachusetts, where
all of the back-office activities are located. The segment operates in two
separate formats. The first operating format consists of 10 sales and recruiting
hubs that manage client orders submitted from anywhere in the country and
fulfill those orders with appropriate candidates identified from a nationwide
database of skilled IT and engineering professionals. The right candidates for
these assignments often reside in locations that are remote from the client
worksite and will travel away from their homes to perform the assignments. The
second operating format consists of 10 branch offices that typically receive
orders from clients
in their local market and fulfill those orders with professionals from the local
market. In each of these formats, we employ both client-oriented sales people
and recruiters. Because our IT and Engineering segment addresses a wide range of
disciplines within the IT and engineering markets, our sales people and
recruiters generally specialize in a given discipline. We have a sales and
recruiting hub in Cork, Ireland to service the European market. Our competitive
advantage in this segment comes from our effort to respond very quickly with
high quality candidates to a client’s request. 7
Contract
professionals assigned to clients are generally our
employees. Clients provide on-the-job supervisors for these
professionals, control and direct their work and approve all hours
worked. We are responsible for many of the activities typically
handled by the client’s human resources department.
Clients
General
During
the year ended December 31, 2009, we provided contract professionals to
approximately 4,864 clients. In 2009, we had no customers that represented 10
percent or more of our revenues.
All
contract assignments, regardless of their planned length, may be terminated with
limited notice by the client or the contract professional.
Life
Sciences
Our
clients in the Life Sciences segment include biotechnology and pharmaceutical
companies, along with a broad range of clients in food and beverage, medical
device, personal care, chemical, material sciences, energy, education and
environmental industries. Our primary contacts with our clients are a mix of end
users and process facilitators. End users consist of lab directors, managers and
department heads. Facilitators consist of human resource managers, procurement
departments and administrators. Facilitators are more price sensitive than end
users who typically are more focused on technical capabilities. Assignments in
our Life Sciences segment typically have a term of three to six
months.
Healthcare
In our
Healthcare segment, we serve a diverse collection of healthcare clients,
including hospitals, integrated delivery systems, imaging centers, clinics,
physician offices, reference laboratories, universities, managed care
organizations and third-party administrators. In doing so, we address
occupations that require “high demand and highly-skilled” staff, such as
operating room nurses and health information professionals who are essential to
the hospital’s ability to care for patients and maintain business and revenues.
Assignments in our Healthcare segment typically have a term of three to thirteen
weeks.
Physician
Clients
in our Physician segment include hospitals, doctors’ practice groups, large
healthcare systems and government agencies. We are called on to supply temporary
and permanent doctors because of the difficulty that healthcare providers have
finding qualified practitioners. Assignments in our Physician segment typically
have a term of six weeks.
IT
and Engineering
In our IT
and Engineering segment, we supply services to a wide range of clients. Our
clients range from very large companies that may, for example, be installing new
enterprise-wide computer systems and have a need for a project manager with a
certain type of experience to a system integrator who is looking for a similar
person. We can also provide contract professionals with a specific type of
embedded software expertise to a smaller company finishing up the development of
a new product. The disciplines in our IT and Engineering segment are quite
varied in the information technology, hardware/software, engineering and telecom
markets. Assignments in our IT and Engineering segment typically have a term of
approximately five months.
The
Contract Professional
General
Contract
professionals often work with a number of staffing companies and develop
relationships or loyalty based on a variety of factors, including competitive
salaries and benefits, availability and diversity of assignments, quality and
duration of assignments and responsiveness to requests for placement. Contract
professionals seeking traveling positions are also interested in the quality of
travel and housing accommodations as well as the quality of the clinical
experience while on assignment. 8
Hourly
wage or contract rates for our contract professionals are established based on
their specific skills and whether or not the assignment involves travel away
from the professional’s primary residence. Our staffing
consultants are our employees or are subcontracted from other affiliated
corporate entities. For our consultant employees we pay the related
costs of employment including social security taxes, federal and state
unemployment taxes, workers’ compensation insurance and other similar costs.
After achieving minimum service periods and hours worked, we also provide our
contract professional employees with paid holidays, and allow participation in
our 401(k) Retirement Savings Plan.
Life
Sciences
Our Life
Sciences segment’s professionals include chemists, clinical research associates,
clinical lab assistants, engineers, biologists, biochemists, microbiologists,
molecular biologists, food scientists, regulatory affairs specialists, lab
assistants and other skilled scientific professionals. These contract
professionals range from individuals with bachelor’s and/or master’s degrees and
considerable experience, to technicians with limited chemistry or biology
backgrounds and lab experience.
Healthcare
Our
Healthcare segment’s contract professionals include nurses, specialty nurses,
health information management professionals, pharmacists, pharmacy technicians,
dentists, respiratory therapists, rehabilitation professionals, surgical
technicians, imaging technicians, medical technologists,
phlebotomists, coders, billers, medical assistants, dental assistants,
hygienists, claims processors and collections staff.
Physician
The
physicians in our Physician segment, come from 33 different specialties
including emergency medicine, psychiatry, anesthesiology, radiology, family
practice, surgical specialties, internal medicine, pediatrics, obstetrics and
gynecology. All of these professionals are independent contractors.
IT
and Engineering
Our IT
and Engineering segment’s professionals come from various information
technology, hardware/software, telecom and engineering disciplines. Typically,
they have a great deal of knowledge and experience in a fairly narrow field
which makes them uniquely qualified to fill a given assignment.
Strategy
We remain
committed to growing our operations in the life science, healthcare, physician
and IT and engineering markets that we currently serve, primarily through
supporting our core service offerings and growing our newer service lines of
business.
In 2009,
we continued to focus on increasing market share in each of our segments,
increasing our gross margins, and controlling our operating costs. We
have increased interaction between our segments so that each can learn best
practices from the others. In the fourth quarter of 2008, we began to
feel the impact of the weakening worldwide economy. Given this change
in market demand, we shifted our focus to the areas that we can control, which
not only includes the management of margins and operating costs, but also the
generation of cash.
In
January 2007, we completed the acquisitions of VISTA and Oxford. Throughout the
balance of 2007, our strategy was in great part focused on assisting the newly
acquired Physician and IT and Engineering segments to continue to perform while
integrating with and operating as a part of On Assignment. In doing this, we
focused on increasing the number of staffing consultants in each segment. We
also focused on diversifying our client mix in the Healthcare segment through
the expansion of our client base. In addition, during 2007, we were successful
maintaining our pricing in all of our segments while controlling operating
costs.
As part
of our initiative to improve our sales capabilities, we completed Phases I, II
and III of the implementation of Vurv Technology (formerly known as RecruitMax),
a front office system, for our domestic Life Sciences and certain Allied
Healthcare service lines of business in 2006 and 2007. Phase IV of the
implementation for our Nurse Travel line of business was completed in the fourth
quarter of 2008. The application interfaces with the existing enterprise-wide
information system, PeopleSoft, used in our Life Sciences, IT and Engineering,
Nurse Travel and Allied Healthcare lines of business and provides additional
functionality, including applicant tracking and search tools, customer and
candidate contact
management and sales management tools. Phase V of the implementation, which will
support our IT and Engineering segment, is expected to be completed within the
next eighteen months. We believe these improvements should continue to increase
the productivity of our staffing consultants and streamline corporate
operations. 9
In 2010,
we anticipate that the markets we serve will improve with the economy. We have
made small investments in enhancing our permanent placement capabilities and we
will continue to invest in our existing businesses to support growth. In
addition, we will continue to review acquisition opportunities that may enable
us to leverage our current infrastructure and capabilities, increase our service
offerings and expand our geographic reach.
Competition
General
Many of
our competitors are larger than us and have substantially greater financial and
marketing resources than we do. We also compete with privately-owned temporary
staffing companies on a regional and local basis. Frequently, the strongest
competition in a particular market is a privately-held local company with
established relationships. These companies oftentimes are extremely competitive
on pricing. While their pricing strategies are not necessarily sustainable, they
can be problematic for us in the short-term.
The
principal competitive factors in attracting qualified candidates for temporary
employment or engagements are salaries, contract rates and benefits,
availability and variety of assignments, quality and duration of assignments and
responsiveness to requests for placement. We believe that many people seeking
temporary employment or engagements through us are also pursuing employment
through other means, including other temporary staffing. Therefore, the speed at
which we place prospective contract professionals and the availability of
appropriate assignments are important factors in our ability to complete
assignments of qualified candidates. In addition to having high quality contract
professionals to assign in a timely manner, the principal competitive factors in
obtaining and retaining clients in the temporary staffing industry are properly
assessing the clients’ specific job requirements, the appropriateness of the
contract professional assigned to the client, the price of services and the
monitoring of client satisfaction. Although we believe we compete favorably with
respect to these factors, we expect competition to continue to
increase.
Life
Sciences
Our Life
Sciences segment competes in the biotechnology, pharmaceutical, food and
beverage, medical device, personal care, chemical, material sciences, energy,
education and environmental markets. We believe our Life Sciences segment is one
of the few nationwide temporary staffing providers specializing exclusively in
the placement of life science professionals. Although other nationwide temporary
staffing companies compete with us with respect to scientific, clinical
laboratory, medical billing and collection personnel, many of these companies
focus on office/clerical and light and heavy industrial personnel, which account
for a significant portion of the overall contract staffing market. These
competitors include Manpower, Inc., Kelly Services, Inc., Adecco SA,
Yoh Company and the Allegis Group.
Healthcare
Our
Healthcare segment competes in the healthcare market, serving hospitals,
integrated delivery systems, imaging centers, clinics, physician offices,
reference laboratories, universities, managed care organizations and third-party
administrators. In the Nurse Travel line of business, our competitors include
AMN Healthcare Services, Inc., Cross Country, Inc. and several
privately-held companies. In the Allied Healthcare line of business, our
competitors include Cross Country, Inc., AMN Healthcare Services, Inc., Kforce
Inc. and the Allegis Group.
Physician
Our
Physician segment also competes in the healthcare market, serving hospitals,
doctors’ practice groups and private healthcare systems and government
administrated healthcare agencies. VISTA’s competitors include CHG Healthcare
Services, TeamHealth, Inc., Cross Country, Inc. and AMN Healthcare
Services, Inc., along with several other privately-held companies providing
locum tenens.
IT
and Engineering
Our IT
and Engineering segment competes in the higher-end of the market for information
technology and engineering consultants. Our IT specialties include
enterprise resource planning, business intelligence, customer relationship
management, supply chain management and database administration. Our
engineering specialties include hardware, software, mechanical, electrical,
validation, network, and telecommunications. Oxford’s competition ranges from
local and regional specialty staffing companies to large IT consulting firms
like Accenture, Inc., International Business Machines Corporation (IBM) and the
Yoh Company, and international staffing firms such as Aerotek and Robert Half
International, Inc. 10
Seasonality
Demand
for our staffing services historically has been lower during the first and
fourth quarters due to fewer business days resulting from client shutdowns,
adverse weather conditions and a decline in the number of contract professionals
willing to work during the holidays. As is common in the staffing
industry, we run special incentive programs to keep our contract professionals,
particularly nurses, working through the holidays. Demand for our staffing
services usually increases in the second and third quarters of the year.
In addition, our cost of services
typically increases in the first quarter primarily due to the reset of payroll
taxes.
Employees
At
December 31, 2009, we employed approximately 932 full-time regular
employees, including staffing consultants, regional sales directors, account
managers, recruiters and corporate office employees. During 2009, we employed
approximately 11,867 contract professionals and 1,016 locum tenens physicians.
Government
Regulation
The
healthcare industry is subject to extensive and complex federal and state laws
and regulations related to professional licensure, certification, conduct of
operations, payment for services, payment for referrals and insurance. Our
operations are subject to additional state and local regulations that require
temporary staffing companies placing healthcare personnel to be licensed or
separately registered to an extent beyond that required by temporary staffing
companies that only place non-healthcare personnel. To date, we have not
experienced any material difficulties in complying with such regulations and
obtaining required licensure.
Some
states require state licensure with associated fees for businesses that employ
and/or assign certain healthcare personnel at hospitals and other healthcare
facilities. We are currently licensed in all the states that require such
licenses. In addition, most of the contract healthcare professionals that we
employ are required to be individually licensed and/or certified under
applicable state laws. We take reasonable steps to ensure that our contract
professionals possess all current licenses and certifications required for each
placement. We provide state mandated workers’ compensation insurance,
unemployment insurance and professional liability insurance for our contract
professionals who are employees and our regular employees. We provide medical
malpractice insurance coverage under VISTA’s group medical malpractice insurance
policy for our locum tenens physicians. These expenses have a direct
effect on our cost of services, margins and likelihood of achieving or
maintaining profitability.
For a
further discussion of government regulation associated with our business, see
“Risk Factors” within Item 1A of Part I of this Annual Report.
Executive
Officers of the Company
The
executive officers of On Assignment, Inc. are as follows:
Peter T. Dameris> joined
the Company in November 2003 as Executive Vice President, Chief Operating
Officer and was promoted to President and Chief Executive Officer in
September 2004. He was appointed to the Board of Directors of the Company
in February 2005. From February 2001 through October 2002,
Mr. Dameris served as Executive Vice President and Chief Operating Officer
of Quanta Services, Inc. (NYSE: PWR), a leading provider of specialized
contracting services for the electric and gas utility, cable and
telecommunications industries. From December 1994 through
September 2000, Mr. Dameris served in a number of different positions
at Metamor Worldwide, Inc., an international, publicly-traded IT
consulting/staffing company, including Chairman of the Board, President and
Chief Executive Officer, Executive Vice President, General Counsel, Senior Vice
President and Secretary. In June 2000, Mr. Dameris successfully
negotiated the sale of Metamor for $1.9 billion. From November 2002 to
January 2006, Mr. Dameris was a member of the Board of
Directors of BindView Corporation (acquired by Symatec Corporation in
January 2006). Mr. Dameris is a member of the Board of Directors
of Seismic Micro-Technology. Mr. Dameris holds a Juris Doctorate
from the University of Texas Law School and a Bachelor’s in Business
Administration from Southern Methodist University. 11
Available
Information and Access to Reports
We
electronically file our Annual Report on Form 10-K, Quarterly Reports on
Form 10-Q, Current Reports on Form 8-K, and all amendments to those
reports with the Securities and Exchange Commission (SEC). You may read and copy
any of our reports that are filed with the SEC in the following
manner:
Our
reports are available through any of the foregoing means and are available free
of charge on our website as soon as practicable after such material is
electronically filed with or furnished to the SEC. Also available on our website
(http://www.onassignment.com),
free of charge, are copies of our Code of Ethics for the Principle Executive
Officer and Senior Financial Officers, Code of Business Conduct and Ethics and
the charters for the committees of our Board of Directors. We intend to disclose
any amendment to, or waiver from, a provision of our Code of Ethics for
Principal Executive Officer and Senior Financial Officers on our website within
five business days following the date of the amendment or waiver
. 12
Item
1A. Risk Factors
Recent
U.S. economic conditions have been uncertain and challenging, which adversely
affects our business and results of operations.
Global
market and economic conditions have been unprecedented and challenging with
tighter credit conditions and recession in most major economies continuing into
2010. Continued concerns about the systemic impact of potential
long-term and wide-spread recession, energy costs, geopolitical issues, the
availability and cost of credit, and the global housing and mortgage markets
have contributed to market volatility and diminished expectations for western
and emerging economies. In 2009, added concerns fueled by the subprime mortgage
crisis, higher interest rates and inflation, federal government stimulus
spending, continued government conservatorship, government financial assistance
and other federal government interventions lead to
increased market uncertainty and instability in both U.S. and international
capital and credit markets. These conditions, combined with volatile
oil prices, lowered business and consumer confidence and high unemployment, have
contributed to economic slowdown and volatility of unprecedented
levels. Further regulation of the healthcare industry also has a
significant effect on spending in this area.
As a
result of these market conditions, the cost and availability of credit has been
and may continue to be adversely affected by illiquid credit markets and wider
credit spreads. Concern about the stability of the markets generally
and the strength of counterparties specifically has led many lenders and
institutional investors to reduce, and in some cases, cease to provide credit to
businesses and consumers. These factors have lead to a decrease in
spending by businesses and consumers alike, and a corresponding decrease in
demand for business services. Continued turbulence in the U.S. and
international markets and economies and prolonged declines in business consumer
spending may adversely affect our liquidity and financial condition, including
our ability to refinance maturing liabilities and access the capital markets to
meet liquidity needs.
Our
liquidity and our ability to obtain financing may be adversely impacted if any
of the lenders under our credit facilities suffers liquidity
issues. In such an event, we may not be able to draw on all, or a
substantial portion, of our credit facilities.
Temporary
staffing companies are negatively impacted by high unemployment rates which have
accompanied this period of economic turbulence. We experienced, and
may continue to experience, a decline in demand for our staffing services as the
U.S. suffers high levels of unemployment.
The
market condition has also affected the liquidity and financial condition of many
of our clients. The problems our clients are experiencing, including
with regard to their access to financing, liquidity issues, funding issues,
creditworthiness and their budgetary constraints may expose us to risks in
collections of our accounts receivable.
Our
results of operations may vary from quarter to quarter as a result of a number
of factors, which may make it difficult to evaluate our business and could cause
instability in the trading price of our common stock.
Factors
that may cause our quarterly results to fluctuate include:
In
addition, most temporary staffing companies experience seasonal declines in
demand during the first and fourth quarters as a result of fewer business days
and the reduced number of contract professionals willing to work during the
holidays. Historically, we have experienced variability in the duration and
depth of these seasonal declines, which in turn have materially affected our
quarterly results of operations and made period-to-period comparisons of our
financial and operating performance difficult.
If our
operating results are below the expectations of public market analysts or
investors in a given quarter, the trading price of our common stock could
decline.
Failure
to comply with restrictive covenants under our debt instruments could trigger
prepayment obligations or additional costs.
13
Failure
of internal controls may leave us susceptible to errors and fraud.
Our
management, including our CEO and CFO, does not expect that our disclosure
controls and internal controls will prevent all errors and all fraud. A control
system, no matter how well conceived and operated, can provide only reasonable
assurance that the objectives of the control system are
met. Furthermore, because of the inherent limitations in all control
systems, no evaluation of controls can provide absolute assurance that all
control issues and instances of fraud, if any, would be detected.
Significant
legal actions could subject us to substantial uninsured
liabilities.
In recent
years, we have been subject to an increasing number of legal actions alleging
malpractice, vicarious liability, intentional torts, negligent hiring,
discrimination or related legal theories. We may be subject to liability in such
cases even if the contribution to the alleged injury was minimal. Many of these
actions involve large claims and significant defense costs. In addition, we may
be subject to claims related to torts or crimes committed by our corporate
employees or contract professionals. In most instances, we are required to
indemnify clients against some or all of these risks. A failure of any of our
corporate employees or contract professionals to observe our policies and
guidelines intended to reduce these risks; relevant client policies and
guidelines or applicable federal, state or local laws, rules and regulations
could result in negative publicity, payment of fines or other
damages.
To
protect ourselves from the cost of these types of claims, we maintain workers’
compensation and professional malpractice liability insurance and general
liability insurance coverage in amounts and with deductibles that we believe are
appropriate for our operations. Our coverage is, in part, self-insured and our
insurance coverage may not cover all claims against us or continue to be
available to us at a reasonable cost. If we are unable to maintain adequate
insurance coverage, we may be exposed to substantial liabilities.
If
we are unable to attract and retain qualified contract professionals for our
Life Sciences, Healthcare, Physician and IT and Engineering segments, our
business could be negatively impacted.
Our
business is substantially dependent upon our ability to attract and retain
contract professionals who possess the skills, experience and, as required,
licenses to meet the specified requirements of our clients. We compete for such
contract professionals with other temporary staffing companies and with our
clients and potential clients. There can be no assurance that qualified
healthcare, nursing, life sciences, physician, IT and engineering professionals
will be available to us in adequate numbers to staff our operating segments.
Moreover, our contract professionals are often hired to become regular employees
of our clients. Attracting and retaining contract professionals depends on
several factors, including our ability to provide contract professionals with
desirable assignments and competitive benefits and wages. The cost of attracting
and retaining contract professionals may be higher than we anticipate and, as a
result, if we are unable to pass these costs on to our clients, our likelihood
of achieving or maintaining profitability could decline. In periods of high
unemployment, contract professionals frequently opt for full-time employment
directly with clients and, due to a large pool of available candidates, clients
are able to directly hire and recruit qualified candidates without the
involvement of staffing agencies. If we are unable to attract and
retain a sufficient number of contract professionals to meet client demand, we
may be required to forgo staffing and revenue opportunities, which may hurt the
growth of our business.
We
may not successfully make or integrate acquisitions, which could harm our
business and growth.
As part
of our growth strategy, we intend to opportunistically pursue selected
acquisitions. We compete with other companies in the professional staffing and
consulting industries for acquisition opportunities, and we cannot assure you
that we will be able to effect future acquisitions on commercially reasonable
terms or at all. To the extent we enter into acquisition transactions in the
future, we may experience:
14
To
undertake more transactions, we may incur additional debt in the future. We may
face unexpected contingent liabilities arising from these or future acquisitions
that could harm our business. We may also issue additional equity in connection
with future transactions, which would dilute our existing
shareholders.
If
we cannot attract, develop and retain qualified and skilled sales and recruiting
staff, our business growth will suffer.
A key
component of our ability to grow our lines of business is our ability to
attract, develop and retain qualified and skilled sales and recruiting staff,
particularly persons with industry experience. The available pool of qualified
staffing consultant candidates is limited, and further constrained by the
industry practice of entering into non-compete agreements with these employees,
which may restrict their ability to accept employment with other staffing firms,
including us. We cannot assure that we will be able to recruit, develop and
retain qualified sales and recruiting staff in sufficient numbers or that our
staffing consultants will achieve productivity levels sufficient to enable
growth of our business. Failure to attract and retain productive sales and
recruiting staff could adversely affect our business, financial condition and
results of operations.
Reclassification
of our independent contractors by tax authorities could materially and adversely
affect our business model and could require us to pay significant retroactive
wages, taxes and penalties.
We
consider our locum tenens physicians to be independent contractors rather than
employees. As such, we do not withhold or pay income or other employment related
taxes or provide workers’ compensation insurance for them. Our classification of
locum tenens physicians as independent contractors is consistent with general
industry standard, but can nonetheless be challenged by the contractors
themselves as well as the relevant taxing authorities. If federal or state
taxing authorities determine that locums tenens physicians engaged as
independent contractors are employees, our business model for that segment would
be materially and adversely affected. Although we believe we would qualify for
safe harbor under the provisions of Section 530 of the Revenue Act of 1978, Pub.
L. No. 95−600 (“Section 530”), and any similar applicable state laws, we could
incur significant liability for past wages, taxes, penalties and other
employment benefits if we could not so qualify. In addition, many states have
laws that prohibit non−physician owned companies from employing physicians. If
our independent contractor physicians are classified as employees, we could be
found in violation of such state laws, which could subject us to liability in
those states and thereby negatively impact on our profitability.
If
our information systems do not function in a cost effective manner, our business
will be harmed.
The
operation of our business is dependent on the proper functioning of our
information systems. In 2009, we continued to upgrade our information technology
systems, including our PeopleSoft and Vurv Technology enterprise-wide
information systems used in daily operations to identify and match staffing
resources and client assignments, track regulatory credentialing, manage
scheduling and also perform billing and accounts receivable functions. If the
systems fail to perform reliably or otherwise do not meet our expectations, or
if we fail to successfully complete the implementation of other modules of the
systems, we could experience business interruptions that could result in
deferred or lost sales. Our information systems are vulnerable to fire, storm,
flood, power loss, telecommunications failures, physical or software break-ins
and similar events. Our network infrastructure is currently located at our
facility in Salt Lake City, Utah. As a result, any system failure or service
outage at this primary facility could result in a loss of service for the
duration of the failure of the outage. Our location in Southern California is
susceptible to earthquakes and has, in the past, experienced power shortages and
outages, any of which could result in system failures or outages. If our
information systems fail or are otherwise unavailable, these functions would
have to be accomplished manually, which could impact our ability to respond to
business opportunities quickly, to pay our staff in a timely fashion and to bill
for services efficiently.
If
we are not able to remain competitive in obtaining and retaining temporary
staffing clients, our future growth will suffer.
15
The
contract staffing industry is highly competitive and fragmented with limited
barriers to entry. We compete in national, regional and local markets with
full-service agencies and in regional and local markets with specialized
contract staffing agencies. Some of our competitors in the Nurse Travel line of
business include AMN Healthcare Services, Inc., Cross
Country, Inc. and several privately-held companies. Some of our competitors
in the Life Sciences segment and Allied Healthcare line of business include
Kelly Services, Inc., Kforce Inc., Manpower, Inc., Adecco, SA, Yoh
Company, and Allegis Group. Competitors for the Physician segment include CHG
Healthcare Services, Cross Country, TeamHealth, Inc. and AMN Healthcare
Services, Inc., along with several other privately-held companies specializing
in locum tenens services. Competitors of our IT and Engineering segment include
Robert Half International, Accenture, Yoh Company and Aerotek. Several of these
companies have significantly greater marketing and financial resources than we
do. Our ability to attract and retain clients is based on the value of the
service we deliver, which in turn depends principally on the speed with which we
fill assignments and the appropriateness of the match based on clients’
requirements and the skills and experience of our contract professionals. Our
ability to attract and retain skilled, experienced contract professionals is
based on our ability to pay competitive wages or contract rates, to provide
competitive benefits and provide multiple, continuous assignments. To the extent
that competitors seek to gain or retain market share by reducing prices or
increasing marketing expenditures, we could lose revenues and our gross and
operating margins could decline, which could seriously harm our operating
results and cause the trading price of our stock to decline. As we expand into
new geographic markets, our success will depend in part on our ability to gain
market share from competitors. We expect competition for clients to increase in
the future, and the success and growth of our business depend on our ability to
remain competitive.
Agreements
may be terminated by clients and contract professionals at will and the
termination of a significant number of such agreements would adversely affect
our revenues and results of operations.
Each
contract professional’s employment or independent contractor’s relationship with
us is terminable at will. A locum tenens physician may generally terminate his
or her contract with VISTA for non-emergency reasons upon 60 days notice. The
duration of agreements with clients are generally dictated by the contract.
Usually, contracts with clients may be terminated with 30 days notice by us or
by the clients and, oftentimes, assignments may be terminated with less than one
week’s notice. We cannot assure that existing clients will continue to use our
services at historical levels, if at all. In addition, we
continue to participate in an increasing number of third party contracts as a
subcontractor and that require us to participate in vendor management contracts,
which may subject us to a greater risks or lower margins. If clients
terminate a significant number of our staffing agreements or assignments and we
are unable to generate new contract staffing orders to replace lost revenues or
a significant number of our contract professionals terminate their employment
with us and we are unable to find suitable replacements, our revenues and
results of operations could be harmed.
We
are subject to business risks associated with international operations, which
could make our international operations significantly more costly.
As of
December 31, 2009, we had international sales in the United Kingdom,
Netherlands, Belgium, Canada, Ireland, Virgin Islands, New Zealand and
Australia. Our international operations comprised approximately 5% of total
sales for each of the three years ended December 31, 2009. We have limited
experience in marketing, selling and, particularly, supporting our services
outside of North America.
Operations
in certain markets are subject to risks inherent in international business
activities, including:
Our
inability to effectively manage our international operations could result in
increased costs and adversely affect our results of operations.
Improper
activities of our contract professionals could result in damage to our business
reputation, discontinuation of our client relationships and exposure to
liability.
We may be
subject to possible claims by our clients related to errors and omissions,
misuse of proprietary information, discrimination and harassment, theft and
other criminal activity, malpractice and other claims stemming from the improper
activities or alleged activities of our contract professionals. We cannot assure
that our current liability insurance coverage will be adequate or will continue
to be available in sufficient amounts to cover damages or other costs associated
with such claims. Claims raised by clients stemming from the improper actions of
our contract professionals, even if without merit, could cause us to incur
significant expense associated with the costs or damages related to such claims.
Further, such claims by clients could damage our business reputation and result
in the discontinuation of client relationships. 16
Claims
against us by our contract professionals for damages resulting from the
negligence or mistreatment by our clients could result in significant costs and
adversely affect our recruitment and retention efforts.
We may be
subject to possible claims by our contract professionals alleging
discrimination, sexual harassment, negligence and other similar activities. Our
physicians, nurses and healthcare professionals may also be subject to medical
malpractice claims. We cannot assure that our current liability insurance
coverage will be adequate or will continue to be available in sufficient amounts
to cover damages or other costs associated with such claims. Claims raised by
our contract professionals, even if without merit, could cause us to incur
significant expense associated with the costs or damages related to such claims.
Further, any associated negative publicity could adversely affect our ability to
attract and retain qualified contract professionals in the future.
If
we are required to further write down goodwill or identifiable intangible
assets, the related charge could materially impact our reported net income or
loss for the period in which it occurs.
We have
approximately $202.8 million in goodwill on our balance sheet at
December 31, 2009, as well as $25.5 million in identifiable intangible
assets. As part of the analysis of goodwill impairment, Accounting Standards
Codification Topic 350, Intangibles - Goodwill and Other, requires
the Company’s management to estimate the fair value of the reporting units on at
least an annual basis and more frequently if events or changes in circumstances
indicate that the carrying amount may not be recoverable. At December 31,
2009, we performed our annual goodwill and indefinite lived intangible assets
impairment test and concluded that there was no further impairment of goodwill
and intangible assets. In addition, at December 31, 2009, we determined that
there were no events or changes in circumstances that indicated that the
carrying values of other identifiable intangible assets subject to amortization
may not be recoverable. While we believe that our goodwill was not impaired at
December 31, 2009, our market capitalization experienced significant declines
during 2009. Declines in our market capitalization or any other
impairment indicators subsequent to the balance sheet date could be an early
indication that goodwill may become impaired in the future. Although
a future impairment of goodwill and identifiable intangible assets would not
affect our cash flow, it would negatively impact our operating
results.
If
we are subject to material uninsured liabilities under our partially
self-insured workers’ compensation program and medical malpractice coverage, our
financial results could be adversely affected.
We
maintain a partially self-insured workers’ compensation program and medical
malpractice coverage. In connection with these programs, we pay a base premium
plus actual losses incurred up to certain levels. We are insured for losses
greater than certain levels, both per occurrence and in the aggregate. There can
be no assurance that our loss reserves and insurance coverage will be adequate
in amount to cover all workers’ compensation or medical malpractice claims. If
we become subject to substantial uninsured workers’ compensation or medical
malpractice liabilities or there is a significant change in the circumstances
related to claims, our results of operations and financial condition could be
adversely affected.
Our
costs of providing travel and housing for traveling contract professionals may
be higher than we anticipate and, as a result, our margins could
decline.
If our
travel and housing costs, including the costs of airline tickets, rental cars,
apartments and rental furniture for our traveling contract professionals exceed
the levels we anticipate, and we are unable to pass such increases on to our
clients, our margins may decline. To the extent the length of our apartment
leases exceed the terms of our staffing contracts, we bear the risk that we will
be obligated to pay rent for housing we do not use. If we cannot source a
sufficient number of appropriate short-term leases in regional markets, or if,
for any reason, we are unable to efficiently utilize the apartments we do lease,
we may be required to pay rent for unutilized or underutilized
housing. Effective management of travel costs will be necessary to
prevent a decrease in gross profit and gross and operating margins.
Demand
for our services is significantly impacted by changes in the general level of
economic activity and continued periods of reduced economic activity could
negatively impact our business and results of operations.
Demand
for the contract staffing services that we provide is significantly impacted by
changes in the general level of economic activity, particularly any negative
effect on healthcare, research and development and quality control and capital
spending. As economic activity slows, many clients or potential clients for our
services reduce their usage of and reliance upon contract professionals before
laying off their regular, full-time employees. During periods of reduced
economic activity, we may also be subject to increased competition for market
share and pricing pressure. As a result, continued periods of reduced economic
activity could harm our business and results of operations.
We
do not have long-term or exclusive agreements with our temporary staffing
clients and growth of our business depends upon our ability to continually
secure and fill new orders. 17
We do not
have long-term agreements or exclusive guaranteed order contracts with our
temporary staffing clients. Assignments for our Life Sciences segment typically
have a term of three to six months. Assignments for our Healthcare segment
typically have a term of two to thirteen weeks. Assignments for our Physician
segment typically have a term of six weeks. Assignments for our IT and
Engineering segment typically have a term of approximately five months. The
success of our business depends upon our ability to continually secure new
orders from clients and to fill those orders with our contract professionals.
Our agreements do not provide for exclusive use of our services, and clients are
free to place orders with our competitors. As a result, it is imperative to our
business that we maintain positive relationships with our clients. If we fail to
maintain positive relationships with these clients, we may be unable to generate
new contract staffing orders, and the growth of our business could be adversely
affected.
Fluctuation
in patient occupancy rates at client facilities could adversely affect demand
for services of our Healthcare and Physician segments and our results of
operations.
Client
demand for our Healthcare and Physician segment services is significantly
impacted by changes in patient occupancy rates at our hospital and healthcare
clients’ facilities. Increases in occupancy often result in increased client
need for contract professionals before full-time employees can be hired. During
periods of decreased occupancy, however, hospitals and other healthcare
facilities typically reduce their use of contract professionals before laying
off their regular, full-time employees. During periods of decreased occupancy,
we may experience increased competition to service clients, including pricing
pressure. Occupancy at certain healthcare clients’ facilities also fluctuates
due to the seasonality of some elective procedures and patients declining
elective procedures. Periods of decreased occupancy at client healthcare
facilities could materially adversely affect our results of
operations.
The
loss of key members of our senior management team could adversely affect the
execution of our business strategy and our financial results.
We
believe that the successful execution of our business strategy and our ability
to build upon the significant recent investments in our business and
acquisitions of new businesses depends on the continued employment of key
members of our senior management team. If any members of our senior management
team become unable or unwilling to continue in their present positions, our
financial results and our business could be materially adversely
affected.
Future
changes in reimbursement trends could hamper our Healthcare and Physician
segments clients’ ability to pay us, which would harm our financial
results.
Many of
our Healthcare and Physician segments’ clients are reimbursed under the federal
Medicare program and state Medicaid programs for the services they provide. In
recent years, federal and state governments have made significant changes in
these programs that have reduced reimbursement rates. In addition, insurance
companies and managed care organizations seek to control costs by requiring that
healthcare providers, such as hospitals, discount their services in exchange for
exclusive or preferred participation in their benefit plans. Future federal and
state legislation or evolving commercial reimbursement trends may further
reduce, or change conditions for, our clients’ reimbursement. Limitations on
reimbursement could reduce our clients’ cash flows, thereby hampering their
ability to pay us.
If
our insurance costs increase significantly, these incremental costs could
negatively affect our financial results.
The costs
related to obtaining and maintaining workers’ compensation insurance, medical
malpractice insurance, professional and general liability insurance and health
insurance for our contract professionals have been increasing. If the cost of
carrying this insurance continues to increase significantly, this may reduce our
gross and operating margins and affect our financial results.
Healthcare
reform could negatively impact our business opportunities, revenues and gross
and operating margins.
The U.S.
government has undertaken efforts to reform the healthcare system through
legislation and regulation. Healthcare reform proposals are generally
intended to expand healthcare coverage for the uninsured and reduce the growth
of total healthcare expenditures. While the U.S. Congress has not adopted any
comprehensive reform proposals, Congress continues to consider such proposals.
If any of these proposals are approved, hospitals and other healthcare
facilities may react by spending less on healthcare staffing, including nurses
and physicians. If this were to occur, we would have fewer business
opportunities, which could seriously harm our business. In addition,
healthcare reform proposals, if approved, may require employers to provide
healthcare insurance coverage to its employees. If we are required to
provide healthcare insurance coverage to our contract employees, we may not be
able to increase client bill rates to cover the additional expense and this may
reduce our gross and operating margins and affect our financial
results. 18
Furthermore,
third-party payers, such as health maintenance organizations, increasingly
challenge the prices charged for medical care. Failure by hospitals and other
healthcare facilities to obtain full reimbursement from those third-party payers
could reduce the demand or the price paid for our staffing
services.
We
operate in a regulated industry and changes in regulations or violations of
regulations may result in increased costs or sanctions that could reduce our
revenues and profitability.
Our
organization is subject to extensive and complex federal and state laws and
regulations including but not limited to laws and regulations related to
professional licensure, payroll tax, conduct of operations, payment for services
and payment for referrals. If we fail to comply with the laws and regulations
that are directly applicable to our business, we could suffer civil and/or
criminal penalties or be subject to injunctions or cease and desist
orders.
Extensive
and complex laws that apply to our hospital and healthcare facility clients,
including laws related to Medicare, Medicaid and other federal and state
healthcare programs, could indirectly affect the demand or the prices paid for
our services. For example, our hospital and healthcare facility clients could
suffer civil and/or criminal penalties and/or be excluded from participating in
Medicare, Medicaid and other healthcare programs if they fail to comply with the
laws and regulations applicable to their businesses. In addition, our hospital
and healthcare facility clients could receive reduced reimbursements or be
excluded from coverage because of a change in the rates or conditions set by
federal or state governments. In turn, violations of or changes to these laws
and regulations that adversely affect our hospital and healthcare facility
clients could also adversely affect the prices that these clients are willing or
able to pay for our services.
We
may be subject to increases in payroll-related costs and state unemployment
insurance taxes which, as a result, our margins could decline.
We currently pay federal, state and
local payroll costs and taxes for our corporate employees and contract
professional employees. If we are subject to significant increases in
costs associated with payroll and state unemployment taxes, we may not be able
to increase client bill rates to cover the additional expense and this may
reduce our gross and operating margins and affect our financial
results.
The
trading price of our common stock has experienced significant fluctuations,
which could make it difficult for us to access the public markets for financing
or use our common stock as consideration in a strategic
transaction.
In 2009,
the trading price of our common stock experienced significant fluctuations, from
a high of $7.52 to a low of $1.28. The closing price of our common stock on The
NASDAQ Global Select Market was $7.06 on March 10, 2010. Our common stock may
continue to fluctuate widely as a result of a large number of factors, many of
which are beyond our control, including:
The stock
market has experienced extreme price and volume fluctuations that have affected
the trading prices of the common stock of many companies involved in the
temporary staffing industry. As a result of these fluctuations, we may encounter
difficulty should we determine to access the public markets for financing or use
our common stock as consideration in a strategic transaction.
19
We cannot
predict what effect, if any, future sales of our common stock, or the
availability of our common stock for sale will have on the market price of our
common stock. Sales of substantial amounts of our common stock in the public
market by management or us, or the perception that such sales could occur, could
adversely affect the market price of our common stock and may make it more
difficult for you to sell your common stock at a time and price which you may
deem appropriate.
We
have adopted anti-takeover measures that could prevent a change in our
control.
In June
2003, we adopted a shareholder rights plan that has certain anti-takeover
effects and will cause substantial dilution to a person or group that attempts
to acquire us in a manner or on terms that have not been approved by our board
of directors. This plan could delay or impede the removal of incumbent directors
and could make more difficult a merger, tender offer or proxy contest involving
us, even if such events could be beneficial, in the short-term, to the interests
of our shareholders. In addition, such provisions could limit the price that
some investors might be wiling to pay in the future for shares of our common
stock. Our certificate of incorporation and bylaws contain provisions that limit
liability and provide for indemnification of our directors and officers, and
provide that our stockholders can take action only at a duly called meeting of
stockholders. These provisions and others also may have the affect of deterring
hostile takeovers or delaying changes in control or management.
Provisions
in our corporate documents and Delaware law may delay or prevent a change in
control that our stockholders consider favorable.
Provisions
in our certificate of incorporation and bylaws could have the effect of delaying
or preventing a change of control or changes in our management. These provisions
include the following:
As a Delaware
corporation, we are also subject to certain Delaware anti-takeover provisions,
including Section 203 of the Delaware General Corporation Law. Under these
provisions, a corporation may not engage in a business combination with any
large stockholders who hold 15 percent or more of our outstanding voting capital
stock in a merger or business combination unless the holder has held the stock
for 3 years, the board of directors has expressly approved the merger or
business transaction or at least two-thirds of the outstanding voting capital
stock not owned by such large stockholder approve the merger or the transaction.
These provisions of Delaware law may have the effect of delaying, deferring or
preventing a change of control, and may discourage bids for our common stock at
a premium over its market price. In addition, our board of directors could rely
on these provisions of Delaware law to discourage, prevent or delay an
acquisition of us.
Item
1B. Unresolved Staff Comments
Item
2. Properties
As of
December 31, 2009, we leased approximately 30,500 square feet of office space
through March 2011 for our field support and corporate headquarters in
Calabasas, California. Additionally, we leased 16,600 square feet of
office space for our field support offices in Blue Ash, Ohio. As of
December 31, 2009, we leased approximately 56,000 square feet of
office space through December 2016 at our VISTA headquarters in Salt Lake City,
Utah, and 48,300 square feet of office space through December 2015 at our Oxford
headquarters in Beverly, Massachusetts. 20
In
addition, we lease approximately 369,000 square feet of office space in
approximately 73 branch office locations in the United States, United Kingdom,
Netherlands, Belgium, Ireland and Canada. A branch office typically occupies
space ranging from approximately 1,000 to 3,000 square feet with lease terms
that typically range from six months to five years.
Item
3. Legal Proceedings
We are involved in
various legal proceedings, claims and litigation arising in the ordinary course
of business. However, based on the facts currently available, we do not believe
that the disposition of matters that are pending or asserted will have a
material adverse effect on our financial position, results of
operations or cash flows.
Item
4. Removed and Reserved
21
Item
5. Market for Registrant’s Common Equity and Related Stockholder
Matters
Our
common stock trades on The NASDAQ Global Select Market under the symbol ASGN.
The following table sets forth the range of high and low sales prices as
reported on The NASDAQ Global Select Market for each quarterly period within the
two most recent fiscal years. At March 10, 2010, we had approximately 41
holders of record, approximately 3,400 beneficial owners of our common stock and
36,371,091 shares outstanding.
Since
inception, we have not declared or paid any cash dividends on our common stock,
and we currently plan to retain all earnings to support the development and
expansion of our business and we have no present intention of paying any
dividends on our common stock in the foreseeable future. However, the board of
directors periodically reviews our dividend policy to determine whether the
declaration of dividends is appropriate. Terms of our senior credit facility
restrict our ability to pay dividends of more than $2.0 million per
year.
On
June 15, 2001, the Company’s Board of Directors authorized the repurchase
of up to 2,940,939 shares of common stock. As of December 31, 2003, the
Company had repurchased 2,662,500 shares of its common stock at a total cost of
$23.0 million. The Company did not repurchase any shares during 2004, 2005 and
2006. In 2007, the Company repurchased the remaining
278,439 shares of its common stock for $2.0 million. At December 31, 2009,
the Company has no remaining authorization to repurchase shares. Effective
December 31, 2009, the Company retired all of its treasury stock.
Stock
Performance Graph
The
following graph compares the performance of On Assignment’s common stock price
during the period from December 31, 2004 to December 31, 2009 with the composite
prices of companies listed on the NASDAQ Stock Market and of companies included
in the SIC Code No. 736—Personnel Supply Services Companies Index. The companies
listed in the SIC Code No. 736 include peer companies in the same industry or
line of business as On Assignment.
The graph
depicts the results of investing $100 in On Assignment’s common stock, the
NASDAQ Stock Market composite index and an index of the companies listed in the
SIC Code No. 736 on December 31, 2004 and assumes that dividends were reinvested
during the period.
The
comparisons shown in the graph below are based upon historical data, and we
caution stockholders that the stock price performance shown in the graph below
is not indicative of, nor intended to forecast, potential future
performance. 22
![]()
23
Item
6. Selected Financial Data
The
following table presents selected financial data of On Assignment. This selected
financial data should be read in conjunction with the consolidated financial
statements and notes thereto included under “Financial Statements and
Supplementary Data” in Part II, Item 8 of this report.
(1) On
January 3, 2007, we acquired VISTA Staffing Solutions, Inc., and on January 31,
2007, we acquired Oxford Global Resources, Inc.
(2) In
2006, there was a reversal of the valuation allowance of $4.9 million that was
recorded against our net deferred income tax assets in 2004 and
2005. 24
Item
7. Management’s Discussion and Analysis of Financial Condition and Results of
Operations
This
discussion contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended. Such statements are based
upon current expectations that involve risks and uncertainties. Any statements
contained herein that are not statements of historical fact may be deemed to be
forward-looking statements. For example, the words “believes,” “anticipates,”
“plans,” “expects,” “intends” and similar expressions that convey uncertainty of
future events or outcomes are forward-looking statements. Forward-looking
statements include statements regarding our anticipated financial and operating
performance for future periods. Our actual results could differ materially from
those discussed or suggested in the forward-looking statements herein. Factors
that could cause or contribute to such differences or prove our forward-looking
statements, by hindsight, to be overly optimistic or unachievable include, but
are not limited to, the following:
For a
discussion of these and other factors that may impact our realization of our
forward-looking statements, see “Risk Factors” within Item 1A of Part I of
this Annual Report on Form 10-K. Other factors may also contribute to the
differences between our forward-looking statements and our actual results. In
addition, as a result of these and other factors, our past financial performance
should not be relied on as an indication of future performance. All
forward-looking statements in this document are based on information available
to us as of the date we file this Annual Report on Form 10-K, and we assume no
obligation to update any forward-looking statement or the reasons why our actual
results may differ.
Overview
On
Assignment, Inc. is a diversified professional staffing firm providing flexible
and permanent staffing solutions in specialty skills including
Laboratory/Scientific, Healthcare/Nursing, Physicians, Medical Financial,
Information Technology and Engineering. We provide clients in these markets with
short-term or long-term assignments of contract professionals,
contract-to-permanent placement and direct placement of these professionals. Our
business currently consists of four operating segments: Life Sciences,
Healthcare, Physician, and IT and Engineering.
Economic
conditions in 2009 were challenging with tight credit markets, volatile
financial markets, low consumer confidence and high unemployment
rates.
Our
consolidated revenues and gross profit decreased in 2009 compared to 2008 as
demand for temporary staffing services weakened as a result of the economic
environment. Despite the decrease in revenues, we remained
disciplined in maintaining margins and positioning our Company for future growth
and profitability. In 2009, we generated higher operating cash flows
than in 2008 and decreased our long-term debt.
Many
strategic factors helped sustain our business during 2009, including our
business model that includes professional diversification, expanded product
lines and a commitment to excellent service to better serve our end
markets. Our four operating segments, Life Sciences, Healthcare,
Physician and IT and Engineering segments provide a mutually supportive
infrastructure where we share best practices and maximize cross selling
opportunities.
We are
confident that as conditions in the U.S. and global economy improve in 2010, we
will be in a position of great opportunity as companies with a need to create
new jobs, yet with uncertainty about sustainable growth, will turn to
professional staffing firms for their contract needs.
25
Results
of Operations
The
following table summarizes selected income statement data expressed as a
percentage of revenues:
RESULTS
OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2009
COMPARED
WITH THE YEAR ENDED DECEMBER 31, 2008
Revenues.
Revenues
decreased $201.4 million, or 32.6 percent, as a result of weakened demand for
our services in all segments.
Life
Sciences segment revenues decreased $35.8 million, or 27.7 percent. The decrease
in revenues was primarily attributable to a 24.8 percent decrease in the average
number of contract professionals on assignment, as well as a $3.4 million, or
54.8 percent decrease in direct hire and conversion fees. Based on our research
and client feedback, we believe this was a direct result of our clients’
decisions to focus more on cost containment than on completing projects and
developing new products or enhancing existing product lines during this
challenging economic period, decreased venture capital funding in the life
sciences sector, softness in the clinical trials arena, which is closely tied to
the struggling pharmaceutical industry, decreased demand for recent graduates
and lower level scientific skill disciplines.
Healthcare
segment revenues (comprised of our Nurse Travel and Allied Healthcare lines of
business) decreased $83.5 million, or 46.2 percent. Nurse Travel revenues
decreased $69.4 million, or 55.5 percent, to $55.6 million primarily as a result
of a 51.1 percent decrease in the average number of nurses on assignment and a
3.4 percent decrease in the average bill rate. Allied Healthcare revenues
decreased $14.1 million, or 25.3 percent, to $41.5 million due to a 21.1 percent
decrease in the average number of contract professionals on assignment,
partially offset by a 6.5 percent increase in the average bill rate. Based on
our research and client feedback, we believe the decrease in revenues was
attributable to less demand from hospitals and other healthcare facilities as
they reduced their usage of contract professionals in response to declining
patient admissions, endowment balances, reduced charitable contributions and the
inability to access the credit markets during this challenging economic
period.
Physician
segment revenues decreased $1.5 million, or 1.7 percent. The decrease in revenue
was primarily attributable to a 13.2 percent decrease in the average number of
physicians on assignment and a $0.9 million decrease in reimbursable revenue for
billable expenses, partially offset by a 2.3 percent increase in the average
bill rate. Based on industry research and client feedback, we believe
the decrease in revenues reflects the uncertainty surrounding health care reform
and the decline in patient admissions which has slowed down our clients’ hiring
decisions. 26
IT and
Engineering segment revenues decreased $80.6 million, or 36.9
percent. The decrease in revenues was primarily due to a 31.8 percent
decrease in the average number of contract professionals on assignment, an 8.8
percent decrease in the average bill rate and a $3.7 million decrease in
reimbursable revenue for billable expenses. Based on client feedback,
the decrease in revenues was mainly the result of the current economic
environment and the lack of capital available to clients for projects and
programs.
Gross
Profit and Gross Margins.
The
year-over-year gross profit decrease was primarily due to the decline in
revenues in all four segments, partially offset by a 46 basis point expansion in
consolidated gross margin. The increase in gross margin was primarily
attributable to margin expansion in the Healthcare and Physician segments and a
shift in mix from our Nurse Travel line of business which has the lowest gross
margin.
Life
Sciences segment gross profit decreased $13.0 million, or 30.0 percent. The
decrease in gross profit was primarily due to a 27.7 percent decrease in the
segment revenues and a 107 basis point contraction in gross margin mainly due to
a $3.4 million decrease in direct hire and conversion fee revenues. The
contraction in gross margin was partially offset by a $0.5 million decrease in
workers’ compensation expense as a result of both lower claim frequency and
favorable settlements.
Healthcare
segment gross profit decreased $18.9 million, or 40.9 percent. The decrease in
gross profit was due to a 46.2 percent decrease in the segment revenues,
partially offset by a 252 basis point expansion in gross margin. The expansion
in gross margin was primarily due to a 117 basis point decrease in travel
related expenses, an 88 basis point reduction in other employee-related expenses
and a 38 basis point decrease in workers’ compensation expense as a result of
our loss control efforts. The expansion in gross margin was partially offset by
an 8.5 percent decrease in the bill/pay spread. Within this segment Allied
Healthcare gross profit decreased 22.4 percent while gross margin expanded 123
basis points and Nurse Travel gross profit decreased 52.4 percent while gross
margin increased 160 basis points.
Physician
segment gross profit increased $1.2 million, or 4.3 percent. The increase in
gross profit was attributable to a 186 basis point expansion in gross margin,
partially offset by a $1.5 million decrease in revenue. The expansion in gross
margin was primarily due to a 6.9 percent increase in the bill/pay spread as
well as a 0.9 million increase in direct hire and conversion fee revenues. The
expansion in gross margin was partially offset by an increase of $0.5 million in
medical malpractice expense, which included a $0.6 million non-cash expense
related to the Company’s adjustment of the discount rate applied to our medical
malpractice liability because of the decrease in interest rates.
IT and
Engineering segment gross profit decreased $32.3 million, or 39.2 percent,
primarily due to a 36.9 percent decrease in revenues and a contraction in gross
margin of 142 basis points. The contraction in gross margin was
primarily due to an 11.3 percent decrease in the bill/pay spread and a $1.0
million decrease in direct hire and conversion fee revenues.
27
Interest
income was $0.2 million and $0.7 million for the years ended 2009 and 2008,
respectively. Interest income in the current period decreased compared to 2008
due to lower account balances invested in interest-bearing accounts and lower
average interest rates.
RESULTS
OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2008
COMPARED
WITH THE YEAR ENDED DECEMBER 31, 2007
Revenues.
Revenues
increased $50.9 million, or 9.0 percent as a result of growth in our Healthcare,
Physician, IT and Engineering segments. The growth was due to both demand in our
end markets, as well as an expanded and more experienced sales and fulfillment
team. In
the latter half of 2007, we made management changes and realigned certain
geographic markets in our Healthcare segment in order to generate higher revenue
growth. The 2008 period included twelve months of activity from the IT and
Engineering segment, as opposed to only eleven months in the 2007
period.
Life
Sciences segment revenues decreased $5.1 million, or 3.8 percent. The decrease
in revenues was primarily attributable to a 9.8 percent decrease in the average
number of contract professionals on assignment, a $0.6 million, or 28.3 percent,
decrease in conversion fee revenues and the deteriorating foreign exchange rate
for the British Pound and the Euro combined with a deepening recession in the
United Kingdom and the United States. These decreases were partially
offset by a 5.4 percent increase in the average bill rate and a $0.2 million
increase in permanent placement fees. The year-over-year decrease in revenues
was a direct result of our clients’ decisions to focus more on cost containment
than on completing projects, developing new products or enhancing existing
product lines during this challenging economic period.
The
overall increase in Healthcare segment revenues, which include our Nurse Travel
and Allied Healthcare lines of business, consisted of an increase in both the
Nurse Travel and Allied Healthcare lines of business revenues. Nurse Travel
revenues increased $5.3 million, or 4.4 percent, to $125.1 million. The increase
in revenues was primarily attributable to a 4.0 percent increase in the average
number of nurses on assignment, as well as a 2.9 percent increase in the average
bill rate. The Nurse Travel revenues in 2008 also included $2.4 million related
to supporting a long standing customer that experienced a labor disruption. The Nurse
Travel results include a decrease in revenues derived from hospitals that
experienced labor disruptions, which for the year ended December 31, 2007 were
$2.8 million. Allied Healthcare revenues increased $0.3 million, or
0.6 percent due to a 4.8 percent increase in the average bill rate and an
increase in billable expenses, partially offset by a 6.7 percent decrease in the
average number of contract professionals on assignment. In addition, direct hire
revenues in the Allied Healthcare line of business decreased $0.2 million, or
13.5 percent. 28
Physician
segment revenues increased $14.6 million, or 19.6 percent. The increase in
revenues in 2008 was primarily due to an 11.2 percent increase in the average
number of contract professionals on assignment as well as a 7.3 percent increase
in the average bill rate as a result of a strong demand environment as a result
of a shortage of physicians.
The IT
and Engineering segment revenues increased $35.8 million, or 19.6 percent. The
increase in revenue was primarily due to a 7.3 percent increase in the average
number of contract professionals on assignment, a 3.5 percent increase in the
average bill rate as well as an increase in conversion and direct hire fee
revenue and billable expenses. In addition, revenues for 2007 only included
eleven months of results because the Company completed its acquisition of Oxford
on January 31, 2007.
Gross
Profit and Gross Margins.
The
year-over-year gross profit increase was due to growth in revenues in the IT and
Engineering, Physician and Healthcare segments and a 62 basis point expansion in
consolidated gross margin. The expansion in gross margin was primarily
attributable to increases in margins in the Physician and Healthcare segments
and to a higher proportion of revenues from the IT and Engineering segment,
which has higher gross margins than the other segments. The 2008
period included twelve months of reportable activity from the IT and Engineering
segment as compared with only eleven months in the 2007 period.
Life
Sciences segment gross profit decreased $1.5 million, or 3.4 percent. The
decrease in gross profit was primarily due to a 3.8 percent decrease in the
segment revenues partially offset by an increase of 16 basis points in gross
margin. The increase in gross margin was predominantly due to a 7.1 percent
increase in bill/pay spread as a result of our continued focus on pricing
policies and increased direct hire revenues.
Healthcare
segment gross profit increased $2.0 million, or 4.5 percent. The increase in
gross profit was due to a 3.2 percent increase in the segment revenues and an
increase in gross margin. Gross margin for the segment increased 32 basis points
due to an increase in the bill/pay spread, partially offset by an increase in
other contract employee expenses. This segment includes gross profit from the
Nurse Travel and Allied Healthcare lines of business. Allied Healthcare gross
profit increased 0.7 percent and gross margin increased 2 basis points while
Nurse Travel gross profit increased 7.0 percent and gross margin increased 57
basis points. Gross margins in the first quarter of a year tend to be lower than
the fourth quarter of the preceding year due to the reset of certain payroll
taxes.
Physician
segment gross profit increased $5.6 million, or 25.5 percent. The increase in
gross profit was primarily attributable to a 19.6 percent increase in revenues
as well as an increase in gross margin. Gross margin for the segment increased
145 basis points primarily due to an increase in bill/pay spread, partially
offset by increased medical malpractice expense. The segment began adjusting
bill rates simultaneously with adjustments in the pay rates when possible which
positively impacted the bill/pay spread in 2008.
IT and
Engineering segment gross profit increased $13.9 million, or 20.3 percent,
primarily due to a 19.6 percent increase in revenues, as the 2008 period
included twelve months of reportable activity versus eleven months in 2007, as
well as an increase in gross margin for the segment. Gross margin for the
segment increased 22 basis points, primarily due to an increase in bill/pay
spread and a $0.8 million, or 83.7 percent increase in conversion fee revenue,
partially offset by a $3.2 million, or 31.0 percent increase in other contract
employment expenses.
29
Selling, General
and Administrative Expenses. >SG&A expenses include field
operating expenses, such as costs associated with our network of staffing
consultants and branch offices for our Life Sciences segment and our Allied
Healthcare lines of business, including staffing consultant compensation, rent
and other office expenses, as well as marketing and recruiting for our contract
professionals. Nurse Travel SG&A expenses include compensation for regional
sales directors, account managers and recruiters, as well as rent and other
office
expenses and marketing for traveling nurses. SG&A expenses from our
Physician and IT and Engineering segments include compensation for sales
personnel, as well as rent and other office expenses and marketing for these
segments. SG&A expenses also include our corporate and branch office support
expenses, such as the salaries of corporate operations and support personnel,
recruiting and training expenses for field staff, marketing staff expenses,
rent, expenses related to being a publicly-traded company and other general and
administrative expenses.
SG&A
expenses increased $4.0 million, or 2.6 percent, to $155.9 million from $151.9
million. The increase in SG&A was primarily due to a $10.2 million increase
in compensation and benefits as a result of increased revenues, and SG&A
expenses of the IT and Engineering segment being included for twelve months in
2008 compared to only eleven months in 2007. The increase
in SG&A expense was partially offset by a $7.0 million decrease in
depreciation and amortization expenses, primarily related to a reduction of the
amortization amount for other intangibles in 2008. Total SG&A as a
percentage of revenues decreased to 25.2 percent in the 2008 period from 26.8
percent in the 2007 period, primarily due to decreased depreciation and
amortization expense.
Interest
income was $0.7 million and $1.4 million for the years ended December 31, 2008
and 2007, respectively. Interest income in the current period was also lower due
to lower average interest rates in 2008.
Liquidity
and Capital Resources
Our
working capital at December 31, 2009 was $62.2 million and our cash and cash
equivalents were $26.0 million. Our operating cash flows have been our primary
source of liquidity and historically have been sufficient to fund our working
capital and capital expenditure needs. Our working capital requirements consist
primarily of the financing of accounts receivable, payroll expenses and the
periodic payments of principal and interest on our term loan.
Net cash
provided by operating activities was $42.0 million for 2009 compared with $35.4
million for 2008. This increase was due to cash
generated from the reduction in net operating assets and liabilities during
2009, mainly from lower accounts receivable. The decrease in accounts
receivable reflects the decline in revenues during the year and improved days
sales outstanding.
Net cash
used in investing activities was $13.8 million during 2009 compared
with $17.7 million during 2008, primarily due to lower capital
expenditures. Net cash from investing activities included proceeds of
$0.5 million from insurance settlements in the third quarter of 2009. Capital
expenditures related to information technology projects, leasehold improvements
and various property and equipment purchases during 2009 totaled $4.7 million,
compared with $8.2 million during 2008. We estimate capital expenditures to be
approximately $4.8 million for 2010.
Net cash
used in financing activities was $49.0 million for 2009, compared with net cash
used in financing activities of $8.4 million for 2008. During 2009,
we paid down our term loan facility by $48.0 million compared with $10.0 million
paid down during 2008.
Under
terms of our credit facility, we are required to maintain certain financial
covenants, including a minimum total leverage ratio, a minimum interest coverage
ratio and a limitation on capital expenditures. The facility also restricts our
ability to pay dividends of more than $2.0 million per year. On March 27, 2009,
we entered into an amendment to our credit facility that modified certain
financial covenants. Under the terms of the amended facility, the
maximum total leverage ratio (total debt to EBITDA, as defined by the credit
agreement for the preceding 12 months) is as follows:
30
Additionally,
the minimum interest coverage ratio (EBITDA to interest expense, as defined by
the credit agreement for the preceding 12 months) is 4.00 to 1.00 until
maturity. The amendment also modified the definition of the LIBOR
rate to include a 3.0 percent floor and increased the spread on revolving and
term loans by 150 basis points to 3.75 percent. As a condition to the
effectiveness of the amendment, we paid down the principal balance on the term
loan by $15.0 million. In 2009, we paid down an additional $33.0
million on the principal balance of our term loan. The payments were
sufficient to cover the excess cash flow payment required by the bank, as well
as all minimum quarterly payments until maturity on January 31,
2013. Based on our current operating plan, we believe we will
maintain compliance with the covenants contained in our credit facility for the
next 12 months.
The VISTA
earn-out related to the 2008 operating performance of VISTA was paid in April
2009. We notified the selling shareholders of VISTA of certain claims
for indemnification, totaling $1.4 million, which was recorded as a decrease to
goodwill and an increase in other current assets as of December 31,
2008. We anticipate that the remaining balance of $0.5 million of the
indemnification payments will be settled by the agreement of all applicable
parties to the terms and provisions related to such payment in 2010. In October
2009, we paid $4.8 million of the earn-out related to the 2008 operating
performance of Oxford. The Company has no additional earn-out payment
obligations.
We
continue to make progress on enhancements to our front-office and back-office
information systems. These enhancements include the consolidation of
back-office systems across all corporate functions, as well as enhancements to
and broader application of our front-office software across all lines of
business. The timing of the full integration of information systems used by
VISTA and Oxford will remain a consideration of management.
We
believe that our working capital as of December 31, 2009, our credit facility
and positive operating cash flows expected from future activities will be
sufficient to fund future requirements of our debt obligations, accounts payable
and related payroll expenses as well as capital expenditure initiatives for the
next twelve months.
Commitments
and Contingencies
We lease
space for our corporate and branch offices. Rent expense was $8.2 million in
2009, $9.5 million in 2008 and $8.8 million in 2007.
The following
table sets forth, on an aggregate basis, at December 31, 2009, the amounts
of specified contractual cash obligations required to be paid in the periods
shown (in thousands):
For
additional information about these contractual cash obligations, see Note 7
to our Consolidated Financial Statements appearing in Part II, Item 8 of
this report. Interest payments related to our bank debt are not set forth in the
table above.
As of
December 31, 2009, included in other current assets is a balance of $0.5 million
for claims indemnifiable by the selling shareholders of VISTA, which we
anticipate will be settled by the agreement of all applicable parties to the
terms and provisions related to such payment in 2010. See Note 3 to our
Consolidated Financial Statements appearing in Part II, Item 8 of this
report.
We are partially
self-insured for our workers' compensation liability related to the Life
Sciences, Healthcare and IT and Engineering segments as well as its medical
malpractice liability in relation to the Physician segment. In connection with
this program, we pay a base premium plus actual losses incurred up to certain
levels and are insured for losses greater than certain levels per occurrence and
in the aggregate. The self-insurance claim liability is determined based on
claims filed and claims incurred but not yet reported. We account for claims
incurred but not yet reported based on estimates derived from historical claims
experience and current trends of industry data. Changes in estimates,
differences in estimates and actual payments for claims are recognized in the
period that the estimates changed or payments were made. The self-insurance
claim liability was approximately $10.3 million and $9.8 million at
December 31, 2009 and 2008, respectively. Additionally, we
have letters of credit outstanding to secure obligations
for workers’ compensation claims with various insurance
carriers. The letters of credit outstanding at December 31, 2009 and
2008 were $3.8 million and $3.5 million, respectively.
As
of December 31, 2009 and 2008, we have an income tax reserve in other
long-term liabilities related to our uncertain tax positions of $0.3
million.
31
We are
involved in various other legal proceedings, claims and litigation arising in
the ordinary course of business. However, based on the facts currently
available, we do not believe that the disposition of matters that are pending or
asserted will have a material adverse effect on our consolidated financial
statements.
Off-Balance
Sheet Arrangements
As of
December 31, 2009, the Company had no significant off-balance sheet
arrangements other than operating leases and letters of credit
outstanding.
Accounting
Standards Updates
The Company
adopted the Financial Accounting Standards Board (FASB) Accounting Standards
Codification (ASC) in the quarter ended September 30, 2009. The ASC does not
alter current accounting principles generally accepted in the Unites States of
America (GAAP), but rather integrated existing accounting standards with other
authoritative guidance. The ASC provides a single source of authoritative GAAP
for nongovernmental entities and supersedes all other previously issued non-SEC
accounting and reporting guidance. The adoption of the ASC did not have any
effect on the Company’s consolidated financial statements.
In
January 2010, the FASB issued an update to ASC Topic 820, Fair Value Measurements and
Disclosures (ASC 820), which requires new disclosures for fair value
measurements and provides clarification for existing disclosures requirements.
More specifically, this update will require (a) an entity to disclose separately
the amounts of significant transfers in and out of Levels 1 and 2 fair value
measurements and to describe the reasons for the transfers; and (b) information
about purchases, sales, issuances and settlements to be presented separately
(i.e. present the activity on a gross basis rather than net) in the
reconciliation for fair value measurements using significant unobservable inputs
(Level 3 inputs). This guidance clarifies existing disclosure requirements for
the level of disaggregation used for classes of assets and liabilities measured
at fair value and requires disclosures about the valuation techniques and inputs
used to measure fair value for both recurring and nonrecurring fair value
measurements using Level 2 and Level 3 inputs. The new disclosures and
clarifications of existing disclosure are effective for fiscal years beginning
after December 15, 2009, except for the disclosure requirements related to the
purchases, sales, issuances and settlements in the rollforward activity of Level
3 fair value measurements, which are effective for fiscal years ending after
December 31, 2010. The Company is in the process of evaluating the impact of
this guidance on the Company’s consolidated financial statements, which will be
effective in the quarter ended March 31, 2010.
In
September 2009, the FASB issued an update to ASC Topic 605, Revenue Recognition, which
establishes the criteria for separating consideration in multiple-element
arrangements. The updated guidance requires companies allocating the
overall consideration to each deliverable to use an estimated selling price of
individual deliverables in the arrangement in the absence of vendor-specific
evidence or other third-party evidence of the selling price for the deliverables
and it also provides additional factors that should be considered when
determining whether software in a tangible product is essential to its
functionality. The Company is in the process of evaluating the impact of this
guidance on the Company’s consolidated financial statements, which will be
effective January 1, 2011.
In August
2009, the FASB issued an update to ASC 820 on measuring
liabilities at fair value. The guidance provides clarification that in
circumstances in which a quoted market price in an active market for an
identical liability is not available, an entity is required to measure fair
value using a valuation technique that uses the quoted price of an identical
liability when traded as an asset or, if unavailable, quoted prices for similar
liabilities or similar assets when traded as assets. If none of this information
is available, an entity should use a valuation technique in accordance with
existing fair valuation principles. The Company adopted the
measurement requirements of this guidance in the quarter ended December 31, 2009
with no impact on the consolidated financial statements.
In May
2009, the FASB issued an update to ASC Topic 855, Subsequent Events, on
accounting and disclosure. The Company
adopted this guidance in the quarter ended June 30, 2009 with no impact on the
consolidated financial statements. See Note 1 to our Consolidated Financial
Statements appearing in Part II, Item 8 of this report under Subsequent Events for the
related disclosure required by this standard.
In April 2009, the FASB issued
an update to ASC 820 on determining fair value when the volume and level of
activity for an asset or liability has significantly decreased, and in
identifying transactions that are not orderly. The Company adopted
this guidance in the quarter ended June 30, 2009 with no impact to the
consolidated financial statements.
32
In April
2009, the FASB issued an update to ASC Topic 825, Financial Instruments, to
include additional requirements regarding interim disclosures about the fair
value of financial instruments which were previously only disclosed on an annual
basis. The Company adopted these requirements in the quarter ended June 30,
2009. See Note 12 to our Consolidated Financial Statements appearing in Part II,
Item 8 of this report for the disclosures required by this
standard.
On
January 1, 2009, the Company implemented the deferred provisions under ASC 820
related to non-financial assets and liabilities measured on a non-recurring
basis. See Note 12 to our Consolidated Financial Statements appearing
in Part II, Item 8 of this report for the disclosures required by this
standard.
On
January 1, 2009, the Company adopted the guidance in ASC Topic 815, Derivative Instruments and Hedging
Activities. See Note 13 to our Consolidated Financial Statements
appearing in Part II, Item 8 of this report for the disclosures required by this
standard.
Critical
Accounting Policies
Our
accounting policies are described in Note 1 of the Notes to Consolidated
Financial Statements in Part II, Item 8 of this report. We prepare our financial
statements in conformity with accounting principles generally accepted in the
United States, which require us to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosures of contingent
assets and liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the year. Actual results could differ
from those estimates. We consider the following policies to be most critical in
understanding the judgments that are involved in preparing our financial
statements and the uncertainties that could impact our results of operations,
financial condition and cash flows.
Allowance for Doubtful Accounts and
Billing Adjustments. We estimate an allowance for doubtful accounts as
well as an allowance for billing adjustments related to trade receivables based
on our analysis of historical collection and adjustment experience. We apply
actual collection and adjustment percentages to the outstanding accounts
receivable balances at the end of the period. If we experience a significant
change in collections or billing adjustment experience, our estimates of the
recoverability of accounts receivable could change by a material
amount.
Workers’ Compensation and Medical
Malpractice Loss Reserves. We are partially self-insured for our workers’
compensation liability related to the Life Sciences, Healthcare and IT and
Engineering segments as well as our medical malpractice liability in relation to
the Physician segment. In connection with these programs, we pay a base premium
plus actual losses incurred, not to exceed certain stop-loss limits. We are
insured for losses above these limits, both per occurrence and in the aggregate.
The self-insurance claim liability is determined based on claims filed and
claims incurred but not reported. We account for claims incurred but not yet
reported based on estimates derived from historical claims experience and
current trends of industry data. Changes in estimates and differences in
estimates and actual payments for claims are recognized in the period that the
estimates changed or the payments were made.
Contingencies. We record an
estimated loss from a loss contingency when information available prior to
issuance of our financial statements indicates it is probable that an asset has
been impaired or a liability has been incurred at the date of the financial
statements, and the amount of the loss can be reasonably estimated. Accounting
for contingencies, such as legal settlements, workers’ compensation matters and
medical malpractice insurance matters, requires us to use our judgment. While we
believe that our accruals for these matters are adequate, if the actual loss
from a loss contingency is significantly different than the estimated loss,
results of operations may be over or understated.
Income taxes. We account for
income taxes under the asset and liability method. Deferred tax assets and
liabilities are recognized for the future tax consequences attributable to
differences between the financial statement carrying amounts of existing assets
and liabilities and their respective tax bases. Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be
recovered or settled. The effect on deferred tax assets and liabilities of a
change in tax rates is recognized in income in the period that includes the
enactment date. Deferred tax assets are reduced by a valuation
allowance if it is more likely than not that a portion of the deferred tax asset
will not be realized.
We make a
comprehensive review of our portfolio of uncertain tax positions
regularly. In this regard, an uncertain tax position represents our
expected treatment of a tax position taken in a filed tax return, or planned to
be taken in a future tax return or claim, that has not been reflected in
measuring income tax expense for financial reporting purposes. Until
these positions are sustained by the taxing authorities, we have not recognized
the tax benefits resulting from such positions and report the tax effects as a
liability for uncertain tax positions in our consolidated balance
sheets. 33
Goodwill and Identifiable Intangible
Assets. Goodwill and other intangible assets having an indefinite useful
life are not amortized for financial statement purposes. Goodwill and intangible
assets with indefinite lives are reviewed for impairment on an annual basis as
of December 31, and whenever events or changes in circumstances indicate that
the carrying amount may not be recoverable.
Intangible
assets with indefinite lives consist of trademarks. In order to test the
trademarks for impairment, we determine the fair value of the trademarks and
compare such amount to its carrying value. We determine the fair value of the
trademarks using a projected discounted cash flow analysis based on the
relief-from-royalty approach. The principal factors used in the discounted cash
flow analysis requiring judgment are projected net sales, discount rate,
royalty rate and terminal value assumption. The royalty rate used in the
analysis is based on transactions that have occurred in our
industry. Intangible assets having finite lives are amortized over
their useful lives and are reviewed to ensure that no conditions exist
indicating the recorded amount is not recoverable from future undiscounted cash
flows.
Goodwill
is tested for impairment using a two-step process that begins with an estimation
of the fair value of a reporting unit. This first step is a screen for
impairment and compares the fair value of a reporting unit to its carrying
value. The second step, if necessary, measures the amount of impairment,
if any. We determine the fair value based upon discounted cash flows prepared
for each reporting unit. Cash flows are developed for each reporting unit based
on assumptions including revenue growth expectations, gross margins, operating
expense projections, working capital, capital expense requirements and tax
rates. The multi-year financial forecasts for each reporting unit used in the
cash flow models considered several key business drivers such as new product
lines, historical performance and industry and economic trends, among other
considerations.
The
principal factors used in the discounted cash flow analysis requiring judgment
are the projected results of operations, discount rate, and terminal value
assumptions. The discount rate is determined using the weighted average cost of
capital (WACC). The WACC takes into account the relative weights of
each component of our consolidated capital structure (equity and debt) and
represents the expected cost of new capital adjusted as appropriate to consider
lower risk profiles associated with such things as longer term contracts and
barriers to market entry. It also considers our risk-free rate of
return, equity market risk premium, beta and size premium adjustment. A single
discount rate is utilized across each reporting unit since we do not believe
that there would be significant differences by reporting
unit. Additionally, the selection of the discount rate accounts for
any uncertainties in the forecasts. The terminal value assumptions
are applied subsequent to the tenth year of the discounted cash flow
model.
For
purposes of establishing inputs for the estimated fair value calculations
described above, we applied annual revenue growth rates based on the then
current economic and market conditions and a terminal growth rate of 4.0
percent. These growth factors were applied to each reporting unit for
the purpose of projecting future cash flows. The cash flows as of
December 31, 2008 were discounted at a rate of approximately 12.0
percent. No impairment of goodwill or intangible assets with
indefinite lives was determined to exist as of December 31, 2008.
We
determined that there had been a triggering event as of March 31, 2009 due to
the fact that the market capitalization was below book value, and there was a
significant decline in forecasted cash flows for 2009. We
revised the assumptions used to determine the fair value of each reporting unit
as of March 31, 2009 from those assumptions used at December 31, 2008 to reflect
estimated reductions in future expected cash flows for 2009 and 2010 and to
increase forecasts for 2011 and later years based on our review of the
historical revenue growth rates. The discount rate used was approximately 13.5
percent. The interim analysis performed at March 31, 2009 did not
indicate impairment.
We
determined that there continued to be a triggering event as of June 30, 2009 due
to the fact that our market capitalization continued to be below book value, and
due to additional reductions in forecasted cash flows for 2009 based on actual
results through June 30, 2009. We performed step one of the
impairment analysis as of June 30, 2009. The assumptions used to
determine the fair value of each reporting unit as of June 30, 2009 were revised
from the assumptions used at March 31, 2009 to reflect further reductions in
future expected cash flows for 2009 and 2010, offset by future expected
increases in cash flows from cost savings measures taken in 2009 and revised
cash flow forecasts for later years to incorporate future cost savings resulting
from initiatives which contemplate further synergies from system and operational
improvements in infrastructure and field support. Given the current economic
environment, we evaluated historical revenue growth rates experienced during a
recovery from a recession in establishing inputs. Despite the
significant decline in revenue in 2009 as a result of the economic downturn,
large annual increases were forecasted over the next four to five years
anticipating an economic recovery. Revenue was forecasted to stabilize in the
second half of 2009. Revenue growth rates in the years beginning in
2010 reflect a recovery from the recession, but were within the range of
historical growth rates we have experienced during similar economic
recoveries. The discount rate used was approximately 16.0
percent as of June 30, 2009 due primarily to increases in the cost of debt, the
small company risk premium based on current market capitalization and the
risk-free interest rate in the second quarter. The interim analysis
performed at June 30, 2009 did not indicate impairment. 34
Given that our market capitalization as of June 30, 2009 was significantly below
book value, we performed a review of market-based data to perform the step
one analysis. The market data review included a comparable trading multiple
analysis based on public company competitors in the staffing
industry. We also performed a selected transaction premiums paid
analysis using 2009 transactions with characteristics similar to
ours. Both market analyses were performed on a consolidated
basis to assess the reasonableness of the results of the discounted cash flow
analysis. We performed the market analyses on a consolidated basis
because we did not believe that there were direct competitors with publicly
available financial data that were comparable to each of our reporting
units.
Based on
these analyses, the fair value determination based on the discounted cash flow
model was determined to be reasonable in comparison to the fair values derived
from these other valuation methods.
During
the quarter ended September 30, 2009, overall operating results for our
reporting units, with the exception of the Nurse Travel reporting unit, were
consistent with our forecasts. Additionally, our stock price
increased during the third quarter and the excess of book value over our market
capitalization declined significantly. As a result, with the
exception of the Nurse Travel reporting unit, we determined that none of our
other reporting units had triggering events as of September 30,
2009. We evaluated the Nurse Travel reporting unit and noted no
impairment as of September 30, 2009.
During
the quarter ended December 31, 2009, overall operating results for our reporting
units, with the exception of the Physician reporting unit, were consistent with
our forecasts. Additionally, our stock price continued to increase
during the fourth quarter and the excess of book value over our market
capitalization continued to decline and was within a reasonable
range. We performed the step one analyses for each reporting unit
because December 31 is our annual impairment test date. We noted no
impairment for any of the reporting units as of December 31, 2009. The discount
rate that was used was 16.9 percent. The Company performed a
review of market-based data to perform the step one analysis as part of its
annual impairment test. The market data review included a comparable
trading multiple analysis based on public company competitors in the staffing
industry. The market analysis was performed on a consolidated basis
to assess the reasonableness of the results of the discounted cash flow
analysis. The market analysis was performed on a consolidated basis
because the Company did not believe that there were direct competitors with
publicly available financial data that were comparable to each of our reporting
units. Based on this analysis, the fair value determination based on
the discounted cash flow model was determined to be reasonable in comparison to
the fair values derived from these other valuation methods.
While the
Nurse Travel reporting unit’s revenues declined to an amount which was below our
forecasted amount in the third quarter, it met the forecasted amounts in the
fourth quarter of 2009. Our forecasted revenues for each of the five
years beginning in 2011 are less than 2008 actual revenues. As of
December 31, 2009, the Nurse Travel reporting unit represented 7.6 percent of
our $202.8 million goodwill balance and the estimated fair value of the
reporting unit as determined by the discounted cash flow analysis exceeded the
carrying value by 53.5 percent.
The
current economic environment significantly impacted the results of the IT and
Engineering reporting unit and as a result, the assumptions related to its
forecasts require a higher degree of management estimate and
judgment. The forecasted results, particularly as it relates to
revenue, are dependent on our assumptions about the timing and degree of
recovery for this reporting unit. This is also the case for the Nurse
Travel reporting unit and the related assumptions described
above. The IT and Engineering reporting unit represented 73.2 percent
of our $202.8 million goodwill balance and the percentage by which the estimated
fair value of the reporting unit as determined by the discounted cash flow
analysis exceeded its carrying value at December 31, 2009 was 7.7
percent. We reviewed the reporting unit’s historical revenue growth
over the past ten years noting that the assumptions used for the revenue growth
rates in the discounted cash flow analysis lead to a result 0.5 percent
higher than what the reporting unit had achieved
historically. Our second quarter forecasts projected IT and
Engineering revenues to begin to stabilize in the second half of 2009 and to
increase beginning in 2010. Our third quarter results showed the
stabilization that we anticipated and they achieved growth in the fourth
quarter. Given that our forecasts assume recovery and revenue growth from
the recession beginning in 2010, we have disclosed below the five-year
compounded annual revenue growth rates for periods after the 2009 decline that
were used in the discounted cash flow analysis to show the level of expected
revenue growth after the economic downturn. We have also provided a
comparison below of these revenue growth rates reflected in the discounted cash
flow analysis to the historical five-year compounded annual growth rates. This
comparison demonstrates that the revenue growth rates reflected in the
discounted cash flow analysis were reasonable based on the reporting unit’s
historical financial performance.
The IT
and Engineering reporting unit was heavily impacted by the economic environment
because this business is concentrated in highly specialized projects which
decline significantly when companies are not investing in capital
expenditures. However, historically the reverse has occurred during a
period of economic recovery since the work that the reporting unit performs is
necessary to develop systems or product enhancements. The
ten-year compounded annual revenue growth rate between 2008 and 2018 for the
reporting unit forecasted in the December 31, 2009 analysis was 5.1 percent and
its historical ten-year compounded annual revenue growth rate between 1998 and
2008 was 4.6 percent. Both of these
35
periods
include the impact of an economic decline and a subsequent recovery. Had we
used a ten-year compounded annual revenue growth rate of 4.6 percent in our
discounted cash flow analysis, the percentage by which the estimated fair value
would have exceeded its carrying value at December 31, 2009 was 3.6 percent.
The reporting unit experienced an economic downturn between 2002 and 2003
and as a result, revenues declined by 38.7 percent. When the economy
recovered over the next several years through 2008, the five-year compounded
annual revenue growth rate was 16.3 percent. In the discounted cash
flow analysis, we used a five-year compounded annual revenue growth rate between
2009 and 2014 of 15.9 percent reflecting the expected stabilization of revenues
in the second half of 2009 and the economic recovery at the beginning of 2010,
which we believe is reasonable based on the historical growth rates recovering
from an economic downturn.
The
Physician segment’s revenues were growing the first half of 2009, which was
offset by a recent decline which resulted in a small year-over-year decline of
1.7 percent. We believe that the decline in the Physician reporting
unit is not sustainable and will not significantly impact the forecasts for the
future years. As such,
the five-year compounded annual growth rate for VISTA between 2008 and 2013 has
remained consistent around 6.6 to 6.7 percent between the third and fourth
quarter discounted cash flow analyses. This is based on various factors
such as the growth of the permanent placement business in the third and fourth
quarter which are high margin and the increase in the gross margins throughout
2009. The Physician reporting unit represented 18.3 percent of our
$202.8 million goodwill balance and the percentage by which the estimated fair
value of the reporting unit as determined by the discounted cash flow analysis
exceeded its carrying value at December 31, 2009 was 5.2 percent.
In
addition to the sensitivity to changes in assumptions related to revenue growth
and timing described above, the discounted cash flows and the resulting fair
value estimates of our reporting units are highly sensitive to changes in other
assumptions which include an increase of less than 100 basis points in the
discount rate and/or a less than five percent decline in the cash flow
projections of a reporting unit could cause the fair value of certain
significant reporting units to be below their carrying
value. Additionally, we have assumed that there will be an economic
recovery at the beginning of 2010 for all of the reporting units. Changes in the
timing of the recovery and the impact on our operations and costs may also
affect the sensitivity of the projections including achieving future cost
savings resulting from initiatives which contemplate further synergies from
system and operational improvements in infrastructure and field support which
were included in our forecasts. Ultimately, future changes in these
assumptions may impact the estimated fair value of a reporting unit and cause
the fair value of the reporting unit to be below their carrying value, which
would require a step two analysis and may result in impairment of
goodwill.
Due to
the many variables inherent in the estimation of a business’s fair value and the
relative size of recorded goodwill, changes in assumptions may have a material
effect on the results of our impairment analysis. Downward revisions of our
forecasts, extended delays in the economic recovery, or a sustained decline of
our stock price resulting in market capitalization significantly below book
value could lead to an impairment of goodwill or intangible assets with
indefinite lives in future periods.
Impairment or Disposal of Long-Lived
Assets. We evaluate long-lived assets, other than goodwill and
identifiable intangible assets with indefinite lives, for impairment whenever
events or changes in circumstances indicate that the carrying value of an asset
may not be recoverable. An impairment loss is recognized when the sum of the
undiscounted future cash flows is less than the carrying amount of the asset, in
which case a write-down is recorded to reduce the related asset to its estimated
fair value. There was
no impairment of long-lived assets in 2009, 2008 or
2007.
Business
Combinations. We record acquisition transactions in accordance
with the purchase method of accounting, and therefore this requires us to use
judgment and estimates related to the allocation of the purchase price to the
intangibles assets of the acquisition and the remaining amount, net of assets
and liabilities assumed, to goodwill. On January 1, 2009, we adopted
new accounting guidance for business combinations as issued by FASB which
establishes principles and requirements for how an acquirer in a business
combination recognizes and measures in its financial statements the identifiable
assets acquired, liabilities assumed, and any noncontrolling interests in the
acquiree, as well as the goodwill acquired. Significant changes from previous
guidance resulting from this new guidance include the expansion of the
definitions of a “business” and a “business combination.” For all business
combinations (whether partial, full or step acquisitions), the acquirer will
record 100% of all assets and liabilities of the acquired business, including
goodwill, generally at their fair values; contingent consideration will be
recognized at its fair value on the acquisition date and; for certain
arrangements, changes in fair value will be recognized in earnings until
settlement, Acquisition-related transaction and restructuring costs will be
expensed rather than treated as part of the cost of the acquisition. The new
accounting guidance also establishes disclosure requirements to enable users to
evaluate the nature and financial effects of the business
combination.
Stock-Based
Compensation. We account for restricted stock awards and stock
units based upon the fair market value of our common stock at the date of
grant. Market-based awards are valued using a Monte Carlo
simulation model. Compensation expense for performance-based awards
is measured based on the amount of shares ultimately expected to vest, estimated
at each reporting date based on management’s expectations regarding the relevant
performance criteria. We account for stock options granted and ESPP
shares based on an estimated
fair market value using a Black-Scholes option valuation model. This
methodology requires the use of subjective assumptions, including expected stock
price volatility and the estimated life of each award. The fair value
of equity-based compensation awards less the estimated forfeitures is amortized
over the service period of the award.
36
Item
7A. Quantitative and Qualitative Disclosures about Market
Risk
We are
exposed to certain market risks arising from transactions in the normal course
of business, principally risks associated with foreign currency fluctuations and
interest rates. We are exposed to foreign currency risk from the translation of
foreign operations into U.S. dollars. Based on the relative size and nature of
our foreign operations, we do not believe that a ten percent change in the value
of foreign currencies relative to the U.S. dollar would have a material impact
on our financial statements. Our primary exposure to market risk is interest
rate risk associated with our debt instruments. See “Item
6. Management’s Discussion and Analysis of Financial Condition and
Results of Operations” for further description of our debt
instruments. The interest rate swap that we entered into with a
financial institution on May 2, 2007 expired as of June 30, 2009 in accordance
with the terms of the agreement. Prior to the expiration of the interest rate
swap on June 30, 2009, the Company entered into an interest rate cap contract
effective July 1, 2009, in order to mitigate the interest rate risk as required
by the amended credit agreement. The interest rate cap contract is
for a notional amount of $51.0 million with a one-month LIBOR cap of 3.0 percent
for a term of one year. See Note 13 to Consolidated Financial
Statements in Part II, Item 8 of this report for additional information on
the interest rate swap agreement and interest rate cap contract entered into by
the Company. Excluding the effect of our interest rate swap agreement and
interest rate cap contract, a 1 percent change in interest rates on variable
rate debt would have resulted in interest expense fluctuating approximately $1.0
million and $1.4 million, respectively, during the year ended December 31, 2009
and 2008, respectively. Including the effect of our interest rate swap agreement
and interest rate cap contract, a 1 percent change in interest rates on variable
debt would have resulted in interest expense fluctuating approximately $0.7
million and $0.6 million during the year ended December 31, 2009 and 2008,
respectively. However, given that our loan agreement has an interest
rate floor (3.0 percent in the case of LIBOR), short-term rates would have to
increase by approximately 250 basis points before it would impact us. We have
not entered into any market risk sensitive instruments for trading
purposes.
37
Item
8. Financial Statements and Supplementary Data
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors and Stockholders of On Assignment, Inc.
Calabasas,
California
We have
audited the accompanying consolidated balance sheets of On Assignment, Inc. and
subsidiaries (the "Company") as of December 31, 2009 and 2008, and the related
consolidated statements of operations and comprehensive income, stockholders'
equity, and cash flows for each of the three years in the period ended December
31, 2009. Our audits also included the financial statement schedule listed in
the Index at Item 15. These financial statements and financial statement
schedule are the responsibility of the Company's management. Our responsibility
is to express an opinion on these financial statements and financial statement
schedule based on our audits.
We
conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our
opinion, such consolidated financial statements present fairly, in all material
respects, the financial position of On Assignment, Inc. and subsidiaries as of
December 31, 2009 and 2008, and the results of their operations and their cash
flows for each of the three years in the period ended December 31, 2009, in
conformity with accounting principles generally accepted in the United States of
America. Also, in our opinion, such financial statement schedule, when
considered in relation to the basic consolidated financial statements taken as a
whole, present fairly, in all material respects, the information set forth
therein.
We have
also audited, in accordance with the standards of the Public Company Accounting
Oversight Board (United States), the Company's internal control over financial
reporting as of December 31, 2009, based on the criteria established in Internal Control—Integrated
Framework issued by the Committee of Sponsoring Organizations of the
Treadway Commission and our report dated March 16, 2010 expressed an unqualified
opinion on the Company's internal control over financial reporting.
Los
Angeles, California
March 16,
2010
38
ON
ASSIGNMENT, INC. AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
(In
thousands, except share and per share data)
See notes
to consolidated financial statements.
39
ON
ASSIGNMENT, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(In
thousands, except per share data)
See notes
to consolidated financial statements. 40
ON
ASSIGNMENT, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF STOCKHOLDERS’ EQUITY
(in
thousands, except share data)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||